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5Abstract
The aim of this investigation was to relate the eﬀects of the meta-
bolic control of adult insulin–dependent diabetes mellitus to the pe-
riodontal health of these patients. It has been proposed that long–
term poorly controlled insulin–dependent diabetic (PIDD) subjects
are at risk for periodontal disease. We compared the periodontal
health status of PIDD subjects with controlled insulin–dependent
diabetic (CIDD) subjects in cross–sectional and longitudinal studies.
The proportional distributions of bacterial morphotypes, especially
spirochetes, were also studied. Histopathological features of gingival
tissues were evaluated in 19 PIDD, 10 CIDD, and 10 non–diabetic
control subjects.
At baseline examination, 55 PIDD and 41 CIDD subjects were
examined at the III Department of Medicine, University of Helsinki,
and at the Helsinki Health Centre. The subjects were mostly long–
term (≥ 10 years) insulin–dependent diabetics with an age–range
from 17 to 65 years. Mean glycosylated hemoglobin and blood glu-
cose levels were signiﬁcantly higher in PIDD than CIDD subjects at
baseline (p < 0.001, t–test). Of 71, 38 subjects participated in the
one–year and 22 in the two–year longitudinal study.
Tooth loss was greater in the PIDD than CIDD subjects in the
cross-sectional and longitudinal study. The two–year longitudinal
study revealed that PIDD subjects experienced clearly more gingi-
val inﬂammation and bleeding after probing than did CIDD sub-
jects. Despite similar oral hygiene conditions, the PIDD subjects
exhibited at baseline and at two follow–up examinations more gin-
gival recession than the CIDD subjects (p < 0.05, χ2–test), more
loss of attachment (p < 0.01, χ2–test), and more alveolar bone loss
(p < 0.001, χ2–test), especially in the molar and lower incisor ar-
eas. However, no statistically signiﬁcant diﬀerences were detected
regarding mean probing depths (p > 0.05, t–test).
These data may suggest that poorly controlled diabetes acceler-
ates the progression of periodontitis lesion in the active phase of the
disease. According to the histological ﬁndings, increased plasma cell
numbers with less collagen and fewer ﬁbroblasts were detectable in
the gingival connective tissue of PIDD subjects than in the metabol-
ically balanced CIDD and healthy non–diabetic control subjects.
The composition of the subgingival microﬂora in 106 analyzed
sites, comprising 55 healthy (probing depth < 4mm) and 51 diseased
(probing depth ≥ 4mm) periodontal sites, revealed that the mean
6spirochete and motile rod percentages in deep pockets were signiﬁ-
cantly higher in PIDD than in CIDD subjects (p < 0.01, p < 0.001,
χ2–test).
Overall, these results indicate that long–term metabolic control is
of signiﬁcant importance to insulin–dependent diabetic subjects and
their periodontal health.
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AGEs advanced glycation end–products
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t–test Student’s t–test
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91. Introduction
The disease diabetes mellitus (DM) comprises a heterogenous group
of pathological conditions characterized by altered glucose metabo-
lism (Bennet 1990). The exact molecular etiopathogenesis of insulin–
dependent diabetes mellitus (IDDM) is currently unknown, but an
infection – evidently viral – in genetically susceptible individuals
has been suggested (Yoon 1991, Dennison et al. 1996, A˚kerblom et
al. 1997, Herrath et al. 1997, Herrath & Holz 1997). Non–insulin–
dependent diabetes mellitus (NIDDM) is the most common type of
diabetes, often associated with obesity suggesting a genetic defect
in insulin secretion, insulin resistance, or impaired glucose tolerance
(Watkins et al. 1996, Groop & Tuomi 1997).
The incidence of IDDM in Finland is among the highest in the
world. Since 1953 it has increased almost four–fold from 12 to
45/100 000/year. At the end of 1996, 3.3% of the whole popula-
tion, i.e., 30 000 subjects, were registered as IDDM and 140 000 as
NIDDM patients (Tuomilehto & Reunanen 1997). Of all those with
diabetes in Finland, 25% have clearly poor (GHbA1c ≥ 10%), 45%
poor (GHbA1c ≥ 9%), 17% moderate (GHbA1c 7.1–8.9 %), and only
13% good (GHbA1c ≤ 7%) metabolic control (Kangas 1993).
Altered host defence and inﬂammatory cell mediator responses
have been frequently demonstrated in diabetes, especially in pa-
tients with poor metabolic control (Casey 1990). In poorly con-
trolled IDDM subjects, increased non–enzymatic glycosylation may
dramatically interfere with host defence molecular functions and
host–microbial interactions such as microbial adherence (Ueta et al.
1993, Marova et al. 1995, Perschel et al. 1995, Schubert & Heese-
mann 1995). Regarding the oral defence mechanisms, the decreased
salivary ﬂuid ﬂow in poorly controlled IDDM subjects (Harrison &
Bowen 1987, Field et al. 1997) may result in a selected bacterial
and fungal microﬂora (Trieger & Boguslaw 1990, Thorstensson 1995,
Karjalainen et al. 1996).
DM subjects are 2.3 times more likely to be aﬄicted with peri-
odontal disease than non–diabetic subjects (Grossi et al. 1994), and
several cross–sectional studies of the association between DM and
periodontal diseases have been published (Glavind et al. 1968, Er-
vasti et al. 1985, Sandholm et al. 1989b, Emrich et al. 1991, Tervonen
& Oliver 1993, Thorstensson 1995, Taylor et al. 1996). Nevertheless,
only a few longitudinal studies have succeeded in calculating the
amount of annual loss of attachment and loss of alveolar bone in
IDDM subjects (Tervonen et al. 1991b, Westfelt et al. 1996, Firatli
1997, Taylor & Becker 1998). Long–duration and poor metabolic
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control may be potential risk factors for periodontal disease pro-
gression, especially considering the vascular complications, selected
micro–organisms, as well as the destructive inﬂammatory reaction
of the tooth–supporting tissues. The contribution of these factors to
the development of periodontal disease needs to be evaluated criti-
cally and thoroughly.
2. Review of the literature
2.1. General aspects of diabetes mellitus. DM comprises a het-
erogenous disease group and is according to WHO (1985) divided
mainly into two groups.
Type I, or IDDM, is characterized by the destruction of Langer-
hans’ insulin–producing beta cells. An autoimmune destruction trig-
gered by environmental factors in genetically susceptible individ-
uals leads to the destruction of these beta cells (A˚kerblom et al.
1997). Speciﬁc HLA haplotypes have also been associated with
IDDM (Tuomilehto & Reunanen 1997). Genetic screening appears
essential in the identiﬁcation of individuals at increased risk for
IDDM (A˚kerblom et al. 1997).
Type II, or NIDDM, also called adult–onset diabetes, is a group
of genetically determined diseases controlled by diet and/or hypo-
glycemic agents and/or exogenous insulin (Groop & Tuomi 1997).
NIDDM patients cannot compensate for insulin resistance at hy-
perglycemic levels by increasing insulin secretion (Groop & Tuomi
1997). Uncontrolled IDDM and NIDDM subjects have similar clini-
cal long–term manifestations with retinopathy, angiopathy, neuropa-
thy, nephropathy, and other severe diabetic complications, such as
limb amputations (DCCT 1993, Sowers & Epstein 1995). These
complications can be triggered and aggravated during the course of
an infection (Perschel et al. 1995). On the other hand, an infection
may disrupt the metabolic balance in diabetes, resulting in a need
for higher insulin doses (Perschel et al. 1995).
Metabolic control, an important variable regarding diabetic com-
plications (DCCT 1993, DCCT 1997), can be determined from blood
glucose levels (BGL, mmol/l), and from glycosylated hemoglobin
measurements known as GHbA1c. Realistic DM treatment aims at
GHbA1c levels < 7.5% with reference levels for GHbA1c between 4
and 6%. Reference levels for BGL are 3.5 to 5.5 mmol/l with fast-
ing BGL < 7.8 mmol/l and a two-hour glucose–tolerance test < 10
mmol/l (Yki–Ja¨rvinen 1999). According to the World Health Orga-
nization (WHO), a new classiﬁcation and diagnosis of DM regarding
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fasting blood glucose is suggested to be lowered to 6.1 mmol/l (Al-
berti & Zimmet 1998). Most of the diabetic subjects having their
yearly medical examination at the health care center or the out-
patient clinic at the Helsinki University hospital may be grouped
by the specialist/endocrinologist into two categories describing their
metabolic control (Luukkanen & Ristima¨ki 1991). Of importance
for their grouping of diabetics according to the metabolic control is
that the longitudinal pre–study evaluation of metabolic control is
based upon GHbA1 or GHbA1c measurements, duration of diabetes,
age and sex, occurrence of diabetic complications, insulin resistance,
glucose tolerance, and medication for diabetes. The primary source
of care in Finland for diabetic subjects aged 15 to 64 years is the
health care center for 54%, while 34% used hospital outpatient care,
8% the services of private physicians, and 4% the occupational health
care system (Kangas 1997).
2.2. Host response. Uncontrolled diabetics with periodontal dis-
ease frequently exhibit an altered inﬂammatory cell response, ap-
parently due to defective inﬂammatory cell functions and impaired
neutrophil and monocyte/macrophage functions (Ueta et al. 1993,
Jansen et al. 1994, Iacopino 1995, Brandt et al. 1996, Salvi et al.
1997). Almost all cellular functions of polymorphonuclear neutrophil
(PMN) leukocytes, including chemotaxis and adherence, are reduced
in those with insulin–dependent diabetes (Tater et al. 1987). The
mobilization of speciﬁc lymphocyte sub–populations can be abnor-
mal in hypoglycemic diabetic patients, indicating an immunologi-
cal defect (Fisher et al. 1987, Seymour 1991). Poorly controlled
IDDM subjects are prone to bacterial infections (Yki–Ja¨rvinen et al.
1989, Schubert & Heesemann 1995). Increasing glucose concentra-
tions can reduce the synthesis of collagens and glycosaminoglycans
(GAGs, Willershausen–Zo¨nnchen et al. 1991). Both the functions
of proteins and cells involved in the host defence can be modiﬁed
by non–enzymatic glycosylation (Marova et al. 1995, Chappey et al.
1997, see also 2.4.).
2.3. Periodontal studies.
2.3.1. Clinical cross–sectional studies. DM and periodontal disease
have been extensively studied with varying results (see reviews by
Yalda et al. 1994, Genco 1996, The Research, Science and Therapy
Committee of the American Academy of Periodontology, Dennison
et al. 1996), due to great varieties in grouping populations of di-
abetic subjects, and due to distinctive epidemiological methods in
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recording periodontal disease. However, high prevalences of peri-
odontal disease among patients with diabetes have been found in a
number of studies (Ray & Orban 1950, Wolf 1977, Cianciola et al.
1982, Shlossman et al. 1990, Emrich et al. 1991, Tervonen & Oliver
1993, Grossi et al. 1994, Pinson et al. 1995, Taylor et al. 1996). Di-
abetic children and adolescents with poor metabolic control and/or
organ complications, exert a tendency towards higher gingival index
scores than those without diabetes who are of the same age (Gisle´n
et al. 1980, Gusberti et al. 1983, Harrison & Bowen 1987, Rylan-
der et al. 1987, Novaes Jr. et al. 1991, de Pommereau et al. 1992).
Mattila et al. (1989) and DeStefano et al. (1993) have demonstrated
an association between periodontal and cardiovascular diseases, and
according to Thorstensson (1995), also diabetic nephropathy, includ-
ing microalbuminuria, is associated with severe periodontal disease
in adult long–term IDDM.
Glavind et al. (1968) showed that patients with a diabetes history
longer than 10 years had greater loss of periodontal structures than
did those with a history less than 10 years. They suggested that dia-
betic patients with retinal changes also show greater attachment loss
than do those with no complications, and this ﬁnding has been ver-
iﬁed by several investigators. Other diabetic complications related
to the kidneys, blood circulation, and nephropathy have also been
associated with periodontal disease (von Heinrich 1980, Rylander et
al. 1987, Bacˇic´ et al. 1988, Willershausen–Zo¨nnchen & Hamm 1988,
Karjalainen et al. 1994).
Case reports have shown rapid periodontal destruction to occur
in adults with poorly controlled diabetes and elevated blood glucose
levels (Bartolucci & Parkes 1981, Ainamo et al. 1990), often associ-
ated with increased amounts of dental calculus and attachment loss
(Tervonen & Oliver 1993). Insulin–dependent diabetic patients, irre-
spective of the duration of their disease, have been reported to show
a higher prevalence of gingivitis than those without diabetes (Hugo-
son et al. 1989), and among 40– to 49–year–old long–duration dia-
betic subjects, signiﬁcantly more periodontitis lesions (pocket depths
≥ 6 mm) and alveolar bone loss were found in comparison to non–
diabetic subjects (Bacˇic´ et al. 1988, Thorstensson & Hugoson 1993).
Heavy tobacco smoking also seems to result in pocket formation,
loss of attachment, increased risk for periopathogens, and vascular
changes (Bergstro¨m & Preber 1994, Grossi et al. 1996, Zambon et
al. 1996).
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2.3.2. Clinical longitudinal studies. The literature published on cross–
sectional studies on periodontal disease and diabetes mellitus pro-
vides limited information on the relation between DM and periodon-
tal disease. Williams and Mahan (1960) suggested that diabetic sub-
jects receiving periodontal treatment showed signiﬁcant reduction in
insulin requirements. Miller et al. (1992) observed in a study of 9
insulin–dependent patients that metabolic balance can be beneﬁ-
cially modiﬁed by controlling their periodontal inﬂammation. How-
ever, Tervonen et al. (1991a) did not during their short follow–up
study of three to four months ﬁnd signiﬁcant diﬀerences in gingival
bleeding or periodontal pockets after oral–hygiene instruction, scal-
ing and root planing in 34 IDDM subjects and 45 healthy controls. In
a ﬁve–year follow–up of 20 diabetic and 20 control subjects attending
dental treatment every three month, no signiﬁcant correlation could
be found between changes in bleeding on probing, probing depth,
and mean long–term GHbA1c values (Westfelt et al. 1996). How-
ever, in a 12–month longitudinal study, Tervonen and Karjalainen
(1997) found in 8 adult type I poorly controlled diabetic patients
a faster recurrence of deepened pockets than in 13 with controlled
diabetes and 10 without diabetes. Taylor et al. (1996) suggested,
based on a 2–year longitudinal study on 80 NIDDM subjects, that
severe periodontitis is a risk factor for poor glycemic control. Grossi
et al. (1996) have demonstrated in a one–year longitudinal study in
85 Pima Indians with poorly controlled NIDDM that an improved
periodontal condition with a signiﬁcant gain in attachment levels
and subsequent reduction of periodontal inﬂammation results con-
comitantly in a signiﬁcant reduction of glycosylated hemoglobin.
Firatli (1997) and Novaes et al. (1997) showed that without peri-
odontal treatment, bone or attachment loss occurred more rapidly
in IDDM subjects than in non–diabetic subjects. Smith et al. (1996)
studied 18 IDDM patients during two months, but could ﬁnd no sig-
niﬁcant diﬀerences in their glycosylated hemoglobin A1c levels before
and after non–surgical periodontal therapy. This ﬁnding seemed to
be in agreement with that of Alridge et al. (1995) in their study of 27
IDDM subjects, who, when re–examined after two months, demon-
strated no signiﬁcant improvement in their immediate glycosylated
hemoglobin levels, spite the fact that all periodontal parameters of
these subjects decreased during the study.
Of importance to metabolic control seems to be the long–term
eﬀect of periodontal treatment with strictly controlled plaque condi-
tions in IDDM and NIDDM subjects. Thus, longitudinal site–by–site
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studies may, under well–deﬁned medical conditions, oﬀer new infor-
mation about the relation between diabetes mellitus and periodontal
diseases.
2.4. Microbiological studies. The etiology of periodontal disease
in hyperglycemic IDDM subjects might at least partially be ex-
plained by the selected pathogen microﬂora in the diseased periodon-
tal pocket (Trieger & Boguslaw 1990). Elevated glucose in saliva
(Harrison & Bowen 1987, Field et al. 1997) and gingival crevic-
ular ﬂuid (Ficara et al. 1975), as well as decreased salivary ﬂuid
ﬂow (Harrison & Bowen 1987, Field et al. 1997), may inﬂuence the
plaque bacterial populations by favoring the growth of some bacte-
rial species at the expense of others (Trieger & Boguslaw 1990). It
may also result in increased non–enzymatic glycosylation of proteins
(inﬂammatory mediators, immunoglobulins and other host–response
mediators) and cells involved in the oral cavity/body defense reac-
tions against inﬂammation and infections and lead to modiﬁcations
in their functions involving defense against infections (Morinushi et
al. 1989, Casey 1990).
It has been well documented that Porphyromonas gingivalis can
invade oral epithelial cells (Sandros et al. 1993), and this microbe
was found in IDDM patients to be their most frequently present peri-
odontal pathogen (Grossi et al. 1994, Thorstensson 1995). P. gingi-
valis and Treponema denticola as whole bacterial cells as well as their
potential virulence factors (proteinases surface proteins, lipopolysac-
charides (LPSs)) can activate neutrophil matrix metallo– and serine
proteinases during phagosytosis (Ding et al. 1996, Ding et al. 1997).
Earlier cross–sectional dark ﬁeld microscopy studies on the per-
centage distribution of subgingival bacterial morphotypes have demon-
strated that spirochetes and motile bacteria residing at the most api-
cal level of the periodontal pocket are associated with periodontal
disease (Listgarten & Hellde´n 1978, Lindhe et al. 1980, Listgarten
& Levin 1981, Armitage et al. 1982, Tanner et al. 1984, Zappa et
al. 1986, Slots & Listgarten 1988, Omar et al. 1990). Hyperglycemia
and an abnormal host–defence mechanism may result, in adult long–
term IDDM, in growth of selected pathogenic micro–organisms such
as spirochetes and motile rods.
A few studies (Gusberti et al. 1983, Mashimo et al. 1983, Mandell
et al. 1992) on the distribution of spirochetes and motile bacteria in
the subgingival microﬂora of PIDD and CIDD subjects suggest a re-
lation between poor metabolic control and severe alveolar bone loss.
According to Sandholm et al. (1989a), 85 subjects with IDDM, aged
12 to 18 years, had almost identical proportions of spirochetes and
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ﬂagellated bacteria as 85 non–diabetic age– and sex–matched control
subjects. Sastrowijoto et al. (1990) could ﬁnd neither in deep nor
in shallow periodontitis pockets of 6 PIDD subjects any signiﬁcant
changes in the subgingival ﬂora during an 8–month follow–up. Over-
all, most studies indicate that the periopathogen micro–organisms
in diabetics are no diﬀerent from those seen in non–diabetic sub-
jects. Further studies are needed to establish the true periodontal
pathogenicity of oral spirochetes in poorly controlled diabetes.
2.5. Histological studies. The nature of most of the histological
studies related to diabetes and periodontal disease is descriptive.
There exist, however, acceptable morphometric methods to mea-
sure the cellular and volumetric composition of the subepithelial in-
ﬂamed (ICT) or non–inﬂamed (NCT) connective tissue (Schroeder
& Mu¨nzel–Pedrazzoli 1973, Liljenberg & Lindhe 1980, Berglundh et
al. 1991). None of these numerous descriptive studies on diabetes
have measured the volumetric or cellular composition of the ICT in
PIDD, CIDD, or non-diabetic control subjects, although both cellu-
lar and humoral immune responses have been suggested to be defec-
tive in diabetic patients with periodontitis (Cutler 1991). An altered
inﬂammatory cell response due to defective neutrophil and/or mono-
cyte/macrophage functions in those with poorly controlled diabetes
(McMullen et al. 1981, Oliver et al. 1991) suggests that it might
be useful to evaluate the exact composition of the ICT beneath the
junctional epithelium in metabolically poorly and well–controlled di-
abetic groups.
Prolonged exposure to hyperglycemia may result in vascular dys-
function and cellular changes (Feener & King 1997). Most histologi-
cal studies have demonstrated that small blood vessels of the gingiva
in long–term diabetic patients frequently shows microangiopathic
changes with occlusion, and increased vascular thickness (Hove &
Stallard 1970, von Heinrich 1980, Hiura 1991). These studies have
failed to report metabolic control levels and correlations with other
diabetic complications, such as retinopathy and nephropathy. In an
electron microscopic study by Listgarten et al. (1974), a statistically
signiﬁcant increase in the width of the basement lamina of endothe-
lial cells appeared in 10 IDDM and 10 control subjects, considering
only the smallest thickness measurements per vessel.
Vlassara & Bucala (1995), Berg et al. (1997), and Chappey et al.
(1997) have indicated that microvascular complications due to long–
term hyperglycemia may occur due to modiﬁed proteins, the so–
called advanced glycation end–products (AGEs). Potentially, AGEs
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may also induce oxidant stress in the gingiva, resulting in acceler-
ated periodontal tissue destruction (Schmidt et al. 1996). Vascu-
lar changes have not yet been studied by morphometric methods in
poorly controlled versus controlled insulin–dependent diabetes, nor
has the acellular or the cellular composition of the clinically healthy
diabetic gingiva been compared to the gingiva of non–diabetic sub-
jects.
2.6. Biochemical studies. In diabetes, the periodontium is evi-
dently aﬀected by pathologically elevated collagenase and matrix
metalloproteinase (MMP) activities (Golub et al. 1992, 1997, 1998,
Sorsa et al. 1992a), reduction of collagen and GAG synthesis (Willers-
hausen–Zo¨nnchen et al. 1991), and by other metabolic abnormalities
in periodontal ligament ﬁbroblasts (Sasaki et al. 1992). In this re-
gard, Golub et al. (1983, 1992, 1998) have shown that in germ–
free rats, diabetes increases collagenase levels in gingiva. Oxidants
in concert with other human and potential periodontopathogenic
bacterial proteases are capable of activating the tissue–destructive
neutrophil, endothelial, epithelial, and bone–cell derived pro matrix
metalloproteinases, such as MMP–8 and MMP–13 (Sorsa et al. 1990,
1992a,b, Westerlund et al. 1996, Sorsa et al. 1998). Poorly controlled
diabetic patients with advanced periodontitis have been shown to ex-
press pathologically excessive active matrix metalloproteinase–8/col-
lagenase–2 in their periodontitis gingiva and gingival crevicular ﬂuid
(GCF) (Sorsa et al. 1992a, 1996).
Identiﬁcation of subjects at high risk for periodontal disease has
signiﬁcantly improved during the last decade (Grossi et al. 1996,
Grossi & Genco 1998, Taylor et al. 1998). Understanding of the
host’s pathological features has expanded, and new evidence demon-
strates that the relationship between periodontal disease and dia-
betes with poor metabolic control is not accidental.
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3. Aims of the investigation
• to evaluate the inﬂuence of metabolic control of diabetes
mellitus on periodontal health of those with adult insulin–
dependent diabetes mellitus (I).
• to evaluate in a two–year longitudinal study the healing and/or
progression of periodontitis in those with poorly controlled
and controlled insulin–dependent diabetes mellitus (II, III).
• to compare with dark ﬁeld microscopy the proportional dis-
tribution of bacterial morphotypes, especially spirochetes, in
adults with long–term poorly controlled and controlled dia-
betes mellitus (IV).
• to study histopathological features of clinically healthy gingi-
val connective tissues from poorly controlled and controlled
insulin–dependent diabetics and non–diabetic control sub-
jects (V).
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4. Material and methods
4.1. Subjects. Of 525 subjects, aged 17 to 65 years, with a medi-
cal history of long–term insulin–dependent diabetes mellitus (IDDM)
most for ≥ 10 years (range 5 to 42 years), 317 were studied from 1984
to 1986 and 208 from 1990 to 1993. These patients were treated at
the III Department of Medicine, University of Helsinki, and at two
Helsinki health centers. Based upon their medical records, 183 sub-
jects were included (inclusion criteria: age 17 to 65 years old, IDDM
duration ≥ 10 years). The dental examination revealed 16 eden-
tulous subjects; 14 subjects participated in another study, and 57
subjects were excluded due to various other reasons (e.g., changed
address, severe illness, inability to participate, due to work). The
remaining 96 subjects were allocated into two groups: 55 poorly
controlled insulin–dependent diabetics (PIDD) and 41 controlled
insulin–dependent diabetics (CIDD).
The medical history of the PIDD patients revealed problems in-
volving their diabetes such as BGLs, GHbA1 and/or GHbA1c, the
frequent hyper–or hypoglycemia, albuminuria, glycosuria, serum cho-
lesterol, triglycerides, creatinine, C–peptide; they had recurrent in-
fections, ketoacidosis, glycosuria, diabetic coma, frequent hospital-
izations, and various stages of retinopathy, neuropathy, nephropathy
or other vascular organ complications. Of those with cardiovascular
complications, 70% were PIDD subjects.
The CIDD subjects presented with overall good metabolic control
with acceptable blood glucose levels, lower glycosylated hemoglobin
A1 and/or A1c levels, no ketosis, less hyper– or hypoglycemia, and
few complications from their diabetes. The inter– and intraexaminer
calibration were performed during two additional studies (Safkan &
Knuuttila 1984, Rylander et al. 1987).
4.1.1. Study I. Groups were 44 PIDD and 27 CIDD subjects with a
mean duration of 16.5 years. Of these 71 diabetic patients, 11 PIDD
and 6 CIDD subjects revealed cardiovascular complications.
4.1.2. Studies II and III. Periodontal disease was assessed after one
year from the baseline examination in 38 subjects and after two years
in 22 subjects.
4.1.3. Study IV. Of 47 long–term IDDM subjects in this study, 26
(55%) were identiﬁed as PIDD and 21 (45%) as CIDD subjects.
4.1.4. Study V. Subjects included in the histological study were 29
long–term IDDM (19 PIDD and 10 CIDD) patients, 10 of them with
19
cardiovascular complications. Controls studied were 10 non–diabetic
age– and sex–matched subjects.
4.2. Periodontal variables. Cross–sectional and longitudinal den-
tal examinations were performed by B.S. The examiner was cali-
brated with an electronic periodontal probe at a standardized pres-
sure of 20–25 g (Vine Valley Research, NY, USA), and was unaware
during the periodontal examination of the subject’s group. Loss of
marginal alveolar bone was measured on orthopantomograms taken
at the Department of Oral Diagnosis, with Granex, OP3 (Studies I to
III, V) or PM2002CC (Study IV) orthopantomographic equipment.
Third molars were in all of the studies examined only when they
replaced missing or extracted second molars. Periodontal treatment
comprising scaling and root planing was given to all patients attend-
ing at baseline and at the one–year examination. Clinical recordings
were made for the variables described in Studies I to V.
4.3. Sampling of the subgingival microﬂora. The composition
of the subgingival microﬂora in 106 periodontal pockets of 47 sub-
jects with insulin–dependent diabetes mellitus was examined by the
method of Listgarten and Hellde´n (1978) (Study IV). Of the 106
pockets, 55 were healthy (probing depth < 4 mm) and 51 diseased
(probing depth ≥ 4 mm).
4.4. Sampling of gingival biopsies and sample processing.
Altogether 39 biopsy samples, one biopsy per subject, were taken
from the buccal marginal gingiva. The gingival biopsy sample was
chosen from a well–deﬁned site, which made optimal and standard-
ized biopsy technique possible (Study V). No evident signs of gingivi-
tis or periodontitis were evident at the biopsy sites. Morphometric
analysis was performed by two examiners (S. Mu¨nzel–Pedrazzoli &
B.S.) according to the stereologic point-counting procedure described
by Schroeder (1967), Weibel (1969), Schroeder & Mu¨nzel–Pedrazzoli
(1973), Liljenberg & Lindhe (1980), and Berglundh et al. (1991).
The multi–purpose test system, ﬁtted into the viewing screen of the
table projector unit, consisted of a square frame of deﬁned size and
42 volumetric points (P42, Study V). With this test system, the rel-
ative volume and density of tissue components of ICT as well as of
the area of blood vessels were calculated with the Zeiss Interactive
Digital Analysis System (ZIDAS).
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4.5. Statistics. Severity of diabetes was measured by means of nom-
inal dichotomous variables (e.g., controlled/poorly controlled, pres-
ence or absence of retinopathy). Diabetic subjects were divided into
groups based on numerical recordings of these variables.
Variables describing periodontitis (plaque index, gingival index,
bleeding index, probing depth, gingival recession, loss of attachment
and loss of alveolar bone) or the subgingival microﬂora (cocci, rods,
ﬁlaments and fusiforms, motile rods, spirochetes) were continuous,
and their distributions were compared between the various groups.
In Studies II and III, attachment level and bone level were compared
longitudinally between the PIDD and CIDD groups. The area of the
lumen of the blood vessel was subtracted digitally from that of the
total blood vessel area. When the assumptions of the t–test were
satisﬁed, this test was used to compare the means of the variables
describing periodontitis. If the assumptions of the t–test were not
satisﬁed, the non–parametric χ2–test was used to compare the distri-
bution of the variables among the diﬀerent groups of subjects. The
tests used are indicated in the tables of Studies I to V. The Systat
(SYSTAT, Inc. 1990) and Cellanal (Na¨gli, 1984) programs served for
statistical analysis and data processing with IBM PS/2 and PC Intel
486.
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5. Results
5.1. Medical data. As the mean blood glucose and the GHbA1
levels at baseline were higher in PIDD than CIDD subjects in all
the ﬁve studies, except in Study V, for GHbA1 (p < 0.152, t–test),
this study design oﬀers a good starting–point for the evaluation of
periodontal status in these two groups of subjects.
At the end of the two–year study, GHbA1 levels had improved in
PIDD subjects as compared to levels in CIDD subjects. This ﬁnding
was, however, not signiﬁcant (p = 0.068, t–test, II, III). During the
two–year follow–up, the GHbA1 level improved from 1.4 to 1.8% in
three of ﬁve PIDD subjects undergoing periodontal surgery.
5.2. Age. Mean age was similar in both groups, except in Studies
II and III at baseline of the one–year study, with a slightly higher
mean age of 4.4 years in the PIDD group (p < 0.05, t–test). No
other signiﬁcant diﬀerences occurred in age distribution during the
study (p > 0.05, t–test).
5.3. Results of cross–sectional clinical studies (I to V).
5.3.1. Distribution of remaining teeth. The overall distribution of
remaining teeth demonstrated that the PIDD subjects had lost more
teeth than the CIDD subjects (Study I).
5.3.2. Oral hygiene and gingival conditions. Oral hygiene was in
Studies I, II, III, and V similar in the two groups (p > 0.05, t–test or
χ2–test), but diﬀerent in Study IV (p < 0.01, t–test). In Studies II
and III the PIDD subjects also revealed higher mean gingival index
scores than did CIDD subjects (p < 0.001, t–test).
5.3.3. Probing depth. No statistically signiﬁcant diﬀerences regard-
ing mean probing depths (p > 0.05, t–test) were observed between
the PIDD and CIDD groups in Studies I to V.
5.3.4. Loss of attachment and alveolar bone. In Study I, the tooth–
speciﬁc histogram of the mean attachment and bone level measure-
ments clearly suggested that the PIDD subjects had lost more at-
tachment and more alveolar bone than the CIDD subjects. With
respect to tooth type, the mean proportions of attachment and bone
loss were higher in some of the molars, premolars, canines, and in-
cisors in the PIDD than in the CIDD subjects (p < 0.05, t–test).
These diﬀerences seemed evident, but when all sites of the dentition
were pooled for analysis, they did not reach statistical signiﬁcance.
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The main diﬀerences appeared in the patterns of loss of attach-
ment and alveolar bone around molars and lower incisors (p < 0.03,
p < 0.01, t–test). In Studies II and III, the long–term PIDD sub-
jects had lost more tooth attachment and alveolar bone than the
corresponding CIDD subjects (p < 0.01, p < 0.001, χ2–test). In
Study IV, the PIDD subjects exhibited clearly more loss of alveolar
bone than the CIDD subjects (p < 0.05, t–test). However, in Study
IV, no diﬀerences existed between the PIDD and CIDD groups re-
garding mean attachment levels (p = 0.113, t–test). Furthermore,
in Study V, the PIDD subjects exhibited more loss of attachment
and alveolar bone than did the CIDD subjects (p < 0.001, p < 0.01,
χ2–test).
5.4. Results of longitudinal clinical studies (II and III).
5.4.1. Loss of teeth. By the end of one year, PIDD subjects had
lost 17 teeth, mainly incisors, 1st premolars, and molars, due to
progressive periodontal disease, whereas the CIDD subjects had lost
none. However, at the end of the second year, no further teeth were
lost in either of the two groups.
5.4.2. Oral hygiene and gingival conditions. Both at one and at two
years from baseline, the PIDD and CIDD subjects showed similar
plaque index scores. At one and two years after baseline, the PIDD
subjects exhibited higher mean gingival index scores (p < 0.05, t–
test, II) than did CIDD subjects. This diﬀerence between groups
in Study II was evident also regarding their bleeding index scores
(p < 0.05, χ2–test). The poor gingival conditions improved after
one and two years from baseline in PIDD subjects, but remained,
at the two–year examination, still high as compared to those of the
CIDD subjects (21% vs 3%, II). The PIDD subjects also exhibited
higher percentages of sites with improved bleeding index scores than
did CIDD subjects (p < 0.01, χ2–test).
5.4.3. Loss of attachment and alveolar bone. At the one–year and
two–year examinations, the PIDD subjects had lost more attach-
ment (p < 0.01, χ2–test, Study II) than did CIDD subjects. One
and two years from baseline there appeared a diﬀerence of 0.1–0.3
mm of attachment loss between PIDD and CIDD subjects (Study
II). A diﬀerence was also obvious in regard to the radiographically
determined mean loss of alveolar bone (p < 0.001, χ2–test, Study
II). The two–year longitudinal site–by–site examination of all teeth
revealed more often a loss of ≥ 2 mm of alveolar bone in the PIDD
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than in the CIDD subjects (p < 0.05, χ2–test, Study III). In addi-
tion, at both baseline and follow–up examinations the PIDD subjects
exhibited more gingival recession than did CIDD subjects (p < 0.05,
χ2–test, II).
The present longitudinal ﬁndings demonstrate that PIDD sub-
jects, during their two–year follow–up, have experienced clearly more
loss of attachment and alveolar bone, and also signiﬁcantly more gin-
gival recession than have CIDD subjects.
5.5. Results of the microbiological study (IV). The cross–
sectional morphological study indicated no diﬀerences in relative
numbers of cocci and ﬁliform and fusiform bacteria in < 4 mm sulci
of PIDD and CIDD subjects (p > 0.05, t–test, IV). In periodon-
titis sites with pockets ≥ 4mm the PIDD subjects revealed lower
frequencies of cocci than did CIDD subjects (p < 0.01, χ2–test, IV).
At baseline, the mean percentage of spirochetes and motile rods in
deepened pockets ≥ 4mm were, however, clearly higher in PIDD
than in CIDD subjects. These diﬀerences were statistically signiﬁ-
cant (p < 0.01, p < 0.001, χ2–test, IV).
5.6. Results of the morphometric study (V). The overall volu-
metric (VV) and numeric (NV) composition of the clinically healthy
but histopathologically inﬂamed connective tissue (ICT) was sim-
ilar in the PIDD and control subjects (Table 3, Study V). Light
microscopic analysis of the inﬂamed gingiva revealed that the in-
ﬂammatory cell inﬁltrate in the gingival connective tissue at the
junctional epithelium was larger and extended more laterally and
apically in PIDD than CIDD subjects. The volumetric (VV) data
on the connective tissue of PIDD subjects seemed also to indicate
more chronic inﬂammation than was seen in CIDD subjects. Un-
der similar plaque conditions, the composition of the ICT indicated
elevated plasma cell levels in the diabetic subjects as compared to
those of the control subjects (Table 3, Study V). PMNs were present
in the gingiva of PIDD subjects and to a slightly lesser extent also
in healthy control subjects (31.3± 5.3 [NV x 106] and 25.2± 6.3 [NV
x 106], respectively).
Moreover, ﬁbroblasts (VVFI) occupied less volume in the ICT of
diabetic subjects than of controls (51.3 ±7.3 mm3/100mm3 vs 80.5
± 42.3 mm3/100mm3, Table 3, Study V). In addition, collagen oc-
cupied less of the volume of ICT lesions in diabetic than of control
subjects (12% and 17%, V). The overall histological picture of the
ICT in PIDD patients was thus characterized by a predominance
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of plasma cells rather than of lymphocytes, associated with a clear
reduction in ﬁbroblasts and collagen ﬁbers.
Swollen and proliferated endothelial cells, diminished or a total ab-
sence of pericytes, as well as enlargened Russel bodies were present
in the inﬂamed connective tissue of the gingiva in insulin–dependent
diabetics. Further, capillaries of the gingival ICT seemed more fre-
quently to be obliterated by swollen endothelial cells, with a narrow
capillary lumen, in long–term diabetics than in control subjects. The
mean distance from the lumen to the outer border of the outmost
basement membrane was greater in the non–inﬁltrated connective
tissue (NCT) of the PIDD than in the non–diabetic control subjects
(p < 0.001, t–test, V).
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6. Discussion
The present studies (I to V) have focused on the relation between
adult periodontal disease and poor metabolic control of type I di-
abetic subjects. When all sites of the dentition were pooled in the
ﬁrst cross–sectional study, no statistically signiﬁcant diﬀerences in
the mean periodontal measurements could be detected between the
PIDD and CIDD subjects. In a recent Italian study, Sbordone et al.
(1998) reported that IDDM patients and their healthy cohabiting
siblings displayed no signiﬁcant diﬀerences in these clinical parame-
ters. Their study comprised only 16 patients and 16 controls, many
patients were in relatively good metabolic state, and a subdivision
into PIDD and CIDD would not have been possible without loss
of statistical power. The present cross–sectional study (I), in con-
trast, comprised 44 PIDD and 27 CIDD subjects and provides more
reliable data on the eventual association between periodontal dis-
ease and metabolic control of IDDM subjects. Because it can be
assumed that poor metabolic control may accelerate the progression
of periodontal disease, further evidence was required to specify the
association in the subclasses of diabetic subjects and healthy control
subjects at high risk for periodontal disease.
Despite the evidence that the pooled data from all sites (I) sug-
gested an apparent lack of association between periodontal status
and diabetic control, the tooth–speciﬁc data (I) demonstrated sig-
niﬁcantly more attachment loss and bone loss in PIDD than CIDD
subjects (p < 0.05, p < 0.01, t–test), especially in some molars, pre-
molars, canines, and incisors. Interestingly, Taylor & Becker (1998)
have recently reported an increased eﬃciency of analysis using the
cumulative logistic regression (CLR) instead of ordinary logistic re-
gression (OLR) analysis in 21 NIDDM patients. In contrast to the
OLR, the CLR model provided convincing evidence that the risk for
more severe bone loss progression after two years is greater in sub-
jects with poorly controlled than in subjects with better controlled
NIDDM or in non–diabetic subjects (Taylor & Becker 1998).
The literature addressing studies of the periodontal status of IDDM
subjects has been based on relatively small populations, probably
due to increasing costs of manpower for large epidemiological popu-
lations, and therefore lack statistical power (Grossi & Genco 1998).
However, large populations of Pima Indians have been studied in the
United States and demonstrate convincingly that an increased risk
for periodontal disease in diabetic subjects does exist (Shlossman et
al. 1990, Emrich et al. 1991, Grossi et al.& 1994, Taylor et al. 1996,
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Taylor et al. 1998). Analysis of the literature in favor of the asso-
ciation between metabolic balance and periodontal status discloses
that many of these previous papers dealt with type II diabetes mel-
litus (Shlossman et al. 1990, Emrich et al. 1991, Grossi et al. 1994,
Taylor et al. 1996, Collin et al. 1998) or with mixed patient popu-
lations comprising both type I and II diabetes (Tervonen & Oliver
1993, Westfelt et al. 1996, Christgau et al. 1998). Metabolic con-
trol may be much more pertinent to periodontal status than is the
type of diabetes, but selection of type I diabetes certainly avoids
this possible bias. Furthermore, there are evident genetic (Groop
& Tuomi 1997), etiologic (A˚kerblom et al. 1997), and medical vari-
eties (Tuomilehto & Reunanen 1997) of diabetics belonging to type
II subgroups. Therefore, only type I or IDDM cases were selected
for the present study.
The present study population was randomly chosen from among
525 subjects according to the following criteria: type of diabetes, age
of subject, and duration of diabetes. Regarding the grouping of the
type I patients, their metabolic control was not based upon a single
measurement of glycosylated hemoglobin, but rather on continuous
yearly evaluation of their medical status registered by the special-
ists/endocrinologists at the diabetes clinics (I). It is not possible in a
cross–sectional study (I, IV, V) to evaluate how many of the ”CIDD”
subjects have periods of hyper- or hypoglycemia and actually repre-
sent PIDD, or conversely, how many of the ”PIDD” subjects have
normoglycemia and are misclassiﬁed as a result of sampling method,
e.g. point estimate of blood glucose or GHbA1c. In this respect, lon-
gitudinal studies with yearly retro– and prospective evaluations give
more reliable results than do cross–sectional studies. It is, naturally,
possible that even patients classiﬁed as PIDD or CIDD as a result of
longitudinal medical follow–up may shift category during the course
of the study, but according to observations published by Tervonen
& Oliver (1993), this is relatively rare.
GHbA1c reﬂects the BGL during the preceding 6 to 8 weeks. It
has therefore been used in some earlier studies for the classiﬁcation
of those with IDDM into well, moderately, or poorly controlled sub-
jects (Tervonen & Oliver 1993, Tervonen & Karjalainen 1997). In
the present study, the classiﬁcation of IDDM into CIDD and PIDD
was based on a number of variables, such as BGLs, GHbA1 and/or
GHbA1c, frequency of hypo– or hyperglycemias, and presence or ab-
sence of various micro– and macroangiopathic complications, such as
retino– and nephropathies as well as neuropathies, according to the
evaluation of the specialists/endocrinologists at the diabetes clinics.
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These data are supposed to provide a more reliable classiﬁcation
basis than the use of one or two criteria only.
It is important to observe that subjects with poor diabetic control
may have other severe interfering systemic diseases, manual disabil-
ities, or even blindness, resulting in poor compliance, unsatisfac-
tory dental habits, and advanced periodontal disease (Thorstens-
son et al. 1989). For example, several potential pathomechanisms
which may contribute to that end include insulin resistance asso-
ciated with acute infections (Yki–Ja¨rvinen et al. 1989); advanced
glycosylation end products (AGEs) aﬀecting endothelial cells of the
periodontal tissues (Lalla et al. 1998a); oxidant stress induced by vas-
cular dysfunction (Schmidt et al. 1996, Lalla et al. 1998a); exagger-
ated inﬂammatory, such as prostaglandin E2 (PGE2), interleukin–
1 beta (IL−1β), interleukin–8 (IL–8), and tumor necrosis factor–
alpha (TNF−α), responses in the human periodontium (Salvi et al.
1998); and identiﬁcation of tissue–destructive MMPs in periodontal
tissue and oral ﬂuid of diabetic animals and humans (Ramamurthy &
Genco 1983, Sorsa et al. 1992a, Sorsa et al. 1996, Lalla et al. 1998b).
Further, smoking and extensive subgingival calculus have been iden-
tiﬁed as risk factors for periodontal disease also in diabetic subjects
(Oliver et al. 1998). The clinical association between poor metabolic
control and poor periodontal condition is, indeed, relevant for the
progression of both diseases. We conﬁrmed and extended (I, II, III)
evidence from recent reports and reviews (Shlossman et al. 1990, Em-
rich et al. 1991, Willershausen–Zo¨nnchen et al. 1991, Lo¨e 1993, Ter-
vonen & Oliver 1993, Thorstensson 1995, Ainamo & Ainamo 1996,
Pohjamo 1996, Taylor et al. 1996, Westfelt et al. 1996, Firatli 1997,
Kinane & Chestnutt 1997, Tervonen & Karjalainen 1997, Collin et
al. 1998, Oliver et al. 1998, Soskolne 1998, Taylor et al. 1998) of
the importance of good metabolic control also during a two–year
follow–up in long–term insulin–dependent diabetic subjects.
The prevalence of periodontal disease is known to increase with
age. Nevertheless, age could in none of these cross–sectional studies
(I, IV, V), explain either greater attachment or bone loss in the PIDD
subjects than in the CIDD subjects, despite of the small diﬀerence
of 4.4 years recorded at baseline in the longitudinal studies. Overall,
odd ratios indicated that diabetes, rather than age, increased risk
for developing destructive periodontal disease, and increased it up
to three-fold (Emrich et al. 1991, Grossi et al. 1994).
The loss of study subjects during the follow–up period was rel-
atively substantial (II, III), probably mainly because patients with
diabetes and its complications do not have the strength or interest,
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or both, to be continuously engaged in dental examinations or to
make regular dental visits (Thorstensson et al. 1989, Pohjamo et al.
1995, Rose et al. 1995, Kawamura et al. 1998). Nonetheless, the loss
of subjects with periodontal disease was equally distributed between
the PIDD and CIDD groups, indicating that these two groups were
statistically comparable with each other also at the end of follow–up.
Patients from the CIDD group with the best periodontal status
may have dropped out; such patients may not be motivated to at-
tend regular dental follow–up visits because of their good periodontal
status. In this case, the actual diﬀerence between PIDD and CIDD
groups would have been even greater than that reported (II, III).
Similarly, if the patients with the worst periodontal status from the
PIDD group had dropped out of the study, then again this would be
a bias, one which would decrease rather than increase the assumed
diﬀerence between these two groups. Such patients might leave the
study because they were, to start with, those least motivated to
achieve good metabolic control, to take care of their oral hygiene,
and to attend the dentist for follow–up examinations. In any case,
it seems that the relatively high drop–out rate, which is usual in
these kinds of studies (Cohen et al. 1970, Tervonen & Oliver 1993,
Thorstensson 1995, Pohjamo 1996, Firatli 1997), does not invalidate
the main clinical ﬁndings of the present study. On the contrary, it
appears plausible that the actual diﬀerence is larger than smaller
than that reported here.
Although our longitudinal study (II, Seppa¨la¨ et al. 1993) was the
ﬁrst longitudinal study published on long–term poorly controlled and
well–controlled IDDM subjects with a two–year follow–up, similar
observations have been reported more recently (Tervonen & Kar-
jalainen 1996, Westfelt et al. 1996, Firatli 1997). Firatli reported
(1997) a statistically signiﬁcant diﬀerence in the diabetic group in
clinical attachment loss at baseline and ﬁve years later compared
to that of healthy controls without any periodontal treatment. He
did not, however, study the eﬀect of metabolic control on the degree
of attachment loss. Tervonen and Karjalainen (1996) reported that
eight IDDM patients with severe diabetes, i.e., with poor long–term
control and/or multiple complications, had a signiﬁcantly higher ex-
tent of attachment loss (≥ 2 mm) at baseline and a rapid recurrence
of probing pocket depth (≥ 4 mm) than did those with moderate or
good control, which were comparable to the non–diabetic subjects.
Westfelt et al. (1996) reported, based on their study of 20 moderately
well–controlled diabetic and 20 non–diabetic subjects with moder-
ate to advanced periodontitis, that their periodontal condition was–
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after periodontal therapy– maintained during ﬁve years, as assessed
every third month.
Only a few longitudinal studies analyzing all sites of each denti-
tion site–by–site are available in periodontal research associated with
diabetes mellitus (III), and none of those studies were based upon
randomly chosen populations. Again, our longitudinal study (III,
Seppa¨la¨ & Ainamo 1994) was the ﬁrst longitudinal site–speciﬁc study
published on long–term poorly controlled and controlled IDDM sub-
jects with a two–year follow–up. Technical diﬃculties regarding data
processing were a challenge, and several cross–checkings and analytic
runs of the data were needed to allow the data to be presented in
a well–organized, comprehensible manner. In particular, the site-
speciﬁc changes in PIDD and CIDD subjects have always been ana-
lyzed per subject in order to avoid statistical bias (Papapanou 1997).
Instead of the use of means (I, II), the abilty to evaluate distribution
of periodontally active or stable sites was more informative, produc-
ing data demonstrating sites with both attachment and alveolar bone
gains or losses among all sites (III). Importantly, the PIDD subjects
had more rapidly progressing sites with more loss of attachment and
alveolar bone than did the CIDD subjects (III). Another interest-
ing longitudinal ﬁnding was that the PIDD subjects exhibited more
gingival recession than did the CIDD subjects (II, III).
The tooth–speciﬁc analysis (I) demonstrated that PIDD subjects
with elevated blood glucose and glycosylated hemoglobin levels had
signiﬁcantly more attachment loss than did CIDD subjects, espe-
cially in some of the molars, premolars, canines, and incisors. The
distribution of teeth (I) was very much in accordance with that of
Thorstensson (1995), although some of our subjects had fewer than
10 teeth remaining in each jaw. Local factors such as dental plaque
and calculus, root anatomy and furcations, may at least partially
be responsible for the increased loss of tooth attachment in PIDD
subjects (I to III). Nonetheless, in our studies no statistically sig-
niﬁcant diﬀerences existed in the mean plaque and calculus levels
between the two groups, and therefore plaque and calculus can only
in part explain the diﬀerences in attachment and bone loss, which are
indicators of true periodontal tissue destruction (Papapanou 1997,
Oliver et al. 1998).
The exaggerated inﬂammatory response in diabetic subjects, es-
pecially involving chronic Gram–negative infections, has been sug-
gested to induce insulin resistance (Yki–Ja¨rvinen et al. 1989), and
thus contribute to the hyperglycemia complicating the metabolic
control of diabetes. However, since the degree of insulin resistance
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has not been quantiﬁed during acute infections, the real eﬀect of im-
paired insulin action in diabetic subjects is unknown (Yki–Ja¨rvinen
et al. 1989). Our results demonstrated that the progression of in-
ﬂammatory lesions was more serious in PIDD than in CIDD subjects
during a two–year follow–up (II, III). In particular, the increase in
numbers of periodontal inﬂammatory cells seemed to result in more
destructive loss of bone in poorly controlled than in well–controlled
subjects.
According to the clinical studies, improved metabolic control of
PIDD subjects seemed to be related to their improved periodontal
condition (p < 0.068, t–test, II, III). This ﬁnding coincided with
the ﬁndings of Miller et al. (1992) and Grossi et al. (1996), but
diﬀered from that of Smith et al. (1996). When severe periodontal
or other inﬂammatory diseases such as acute periapical infections
and infected cysts were eliminated either by non–surgical or surgical
methods, a beneﬁcial eﬀect on the metabolic control of IDDM was
achieved (II, III, results section, and unpublished data). On the
other hand, in diabetic subjects with few deep periodontal pockets,
no dramatic eﬀect on their metabolic control could be observed (II,
III).
Poor metabolic control involving diabetic complications was a risk
factor aﬀecting periodontal disease progression and severity, as evi-
denced in Study III (p < 0.05, χ2–test). However, prolonged expo-
sure to hyperglycemia may be the primary factor responsible for the
development of diabetic complications resulting in the formation of
non–enzymatic advanced glycation end–products (AGEs); this has
been demonstrated also in the gingiva of diabetic patients (Schmidt
et al. 1996, Lalla et al. 1998a, Nishimura et al. 1998) and diabetic
animals (Lalla et al. 1998b). AGEs can induce diabetic collagen
cross–links and expansion of extracellular matrix, indicating that
most of the macrovascular complications, such as hardening of ar-
teries and narrowing of vascular lumina, may have been mediated
by elevated glucose levels in serum and body ﬂuids (Dennison 1998,
Grossi & Genco 1998). Further, the AGE–modiﬁed proteins may
bind to the macrophage receptor and possibly increase production
of cytokines, such as IL–1 and TNF−α (Salvi et al. 1998). If syn-
thesis of these cytokines is increased, as in hyperglycemia–induced
excessive AGEs accumulation, a degradative cascade is triggered,
resulting partly in MMP–mediated connective tissue degradation,
endothelial proliferation, and focal thrombosis (Lalla et al. 1998a).
Thorstensson (1996) demonstrated that, in adult long–term IDDM
subjects diabetic nephropathy and cardiovascular complications are
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associated with severe periodontal disease. We found (II, III) that
periodontal treatment does not directly seem to improve the meta-
bolic control of these randomly chosen long–term IDDM subjects,
perhaps partly due to the fact that the inﬂammatory process in the
periodontium may be very local and discrete.
The clinical relevance of these studies (II, III) supports earlier ﬁnd-
ings indicating that even poorly controlled diabetic patients beneﬁt
directly or indirectly from the prevention and treatment of peri-
odontal disease. Because PIDD patients have increased loss of at-
tachment and bone, periodontal treatment is of utmost importance
to prevent further deterioration and, eventually, loss of teeth. Be-
cause metabolic changes aﬀect the development and progression of
vascular complications of IDDM (Diabetes Control and Complica-
tions Trial Research Group, DCCT 1993), it is at least theoretically
important to treat the periodontal diseases in IDDM to diminish the
risk for development of cardiovascular complications (Mattila et al.
1989, DeStefano et al. 1993, Dennison 1998).
Results from microbiological studies on the prevalence of peri-
odontal pathogens in diabetic subjects are somewhat variable (Sas-
trowijoto et al. 1990, Ueta et al. 1993, Grossi et al. 1994, Tervonen
et al. 1994, Thorstensson 1995, Christgau et al. 1998, Collin et al.
1998, Sbordone et al. 1998). Grossi et al. and Thorstensson demon-
strated that signiﬁcantly more diabetic subjects harbored Porphy-
romonas gingivalis than did non–diabetic subjects, but Tervonen et
al., Collin et al., and Sbordone et al. could not demonstrate in well or
moderately controlled diabetic subjects more periodontopathogens,
i.e., Actinobacillus Actinomycetemcomitans, Porphyromonas gingi-
valis, and Prevotella intermedia, than in control subjects. These
various results may originate from diﬀerences in study models (I,
IV), and from methodological diﬀerences used to analyze partly non–
cultivable putative periodontopathogens (Zappa et al. 1986, Ojima
et al. 1998).
In our microbiological study (IV), when both periodontally healthy
and diseased sites were analyzed, motile rods evidently representing
spirochetes of the subgingival microﬂora were more frequent in pe-
riodontal pockets of PIDD than CIDD subjects. Our ﬁnding was
thus in agreement with that of Mashimo et al. (1983), who found
more spirochetes in diabetics than in control subjects (Mashimo et
al. 1983, IV). However, also in healthy sites of PIDD subjects was
an established microﬂora with spirochetes present more frequently
than in the healthy sites of CIDD subjects (p < 0.001, χ2–test, IV),
probably due to the high glucose levels of the GCF (Ficara et al.
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1985). Thus, elevated glucose levels in the GCF of PIDD subjects
may have induced circumstances during an infection favorable for
the growth of a periodontopathogen microﬂora with reduced oxygen
generation in the periodontal tissues during an infection (Ueta et
al. 1993). It is also well documented that diabetics are particularly
susceptible to Candida albicans infections (Hostetter 1990).
Poorly controlled diabetes may, due to defectively functioning
PMNs (Tater et al. 1987, Genco et al. 1990, Cutler et al. 1991,
Marhoﬀer et al. 1992, De Toni et al. 1998), predispose PIDD sub-
jects to a more virulent periodontopathogen microﬂora. Although
our study could not document increased numbers of either PMNs
or monocytes/macrophages in the ICT of PIDD subjects compared
to numbers in non–diabetic control subjects, severe disruptions in
the transmigration and/or function of these cells may occur due to
abnormal exposure to glucose.
Increased cytokine (Iacopino 1995) and neutrophil–type matrix
metalloprotei-nase–8 (MMP–8) or collagenase–2 and gelatinases act
together with dental plaque–derived periodontopathogens and their
virulence factors in diabetic subjects and in animal models of di-
abetes (Sorsa et al. 1992b, Ingman et al. 1996, Sorsa et al. 1996,
Doxey et al. 1998, Lalla et al. 1998a). They may be responsible
for an increase in the inﬂammatory tissue destruction of PIDD pa-
tients with advanced periodontitis (Sorsa et al. 1992a, 1996). It was
of particular interest to observe, in the ICT of PIDD subjects, in-
creased numbers of plasma cells (V) indicating a chronic, indolent
local host–reaction to infective micro–organisms rather than clear
signs of acute inﬂammation. Potentially, the pathogen microﬂora in
hyperglycemic diabetic subjects leads, through exaggerated and/or
prolonged host–responses, to periodontal breakdown. This ﬁnding
was in agreement with ﬁndings of Grossi et al. (1994).
The histological study (V) included measurements of the shortest
distance from the lumen to the outer border of each blood vessel
ﬁnding this distance to be signiﬁcantly greater in PIDD than in con-
trol or CIDD subjects (p < 0.001, t–test, V). Further, comparisons
of the mean areas of circular cross–sections of several small blood
vessels between the age– and sex–matched PIDD, CIDD, and con-
trol subjects showed CIDD subjects to have the smallest and PIDD
subjects the largest mean areas of these three groups. This ﬁnding,
although not statistically signiﬁcant, suggests that well–controlled
diabetic subjects are comparable to non–diabetic control subjects,
but that vascular complications are present in the clinically healthy
gingival tissues of long–term uncontrolled diabetic subjects.
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The PIDD subjects had characteristics of chronic inﬂammation
with a clear predominance of plasma cells and a reduction of ﬁbrob-
lasts as well as decreased collagen in their ICT (V). Based upon
our histomorphometric study (V), the gingival tissues of PIDD sub-
jects demonstrated not only microangiopathic changes but also an
increased number of plasma cells, which characterize the chronic in-
ﬂammatory process of the periodontal connective tissues and the lo-
cal loss of attachment and alveolar bone in diabetic and non–diabetic
subjects. Such a local activation of the inﬂammatory process may
lack clinical relevance, and may not always lead to deepened probing
depths, increased gingival indices, or increased bleeding after prob-
ing measurements, or to both. However, it does seem important to
follow especially the attachment loss measurements, the radiologi-
cal loss of alveolar bone, and those periodontal parameters related
to gingival inﬂammation in diabetic subjects with moderate or se-
vere periodontal disease. The signiﬁcant diﬀerences between PIDD
and CIDD in progression of attachment–loss site–speciﬁcally may
indicate that poorly controlled diabetes accelerates destruction es-
pecially in those periodontitis sites aﬀected by the disease in its
active stage.
Based upon our histopathological results (V), the connective tis-
sue changes may indicate increased degradation of the inﬂamed sites
in gingiva, especially in PIDD subjects. Degenerated cell organs
have also been observed in pericytes and endothelial cells of the mu-
cosal and retinal capillaries, resulting in a narrowed capillary lumen
(Serizawa 1988) as well as in impaired wound healing (Grant–Theule
1996). Hiura (1991) demonstrated that the percentage of capillaries
with layered basement membranes and lysosome–like structures in
their endothelial cells increases in the diabetic group and correlates
with growing degrees of diabetic retinopathy. As PIDD diabetic pa-
tients seem to have more retinopathies than control subjects, Hiura’s
ﬁndings agree well with the current study demonstrating thickening
and obliteration of small arteries and postcapillary venules composed
of endothelial cells and in many places surrounded by pericytes.
Taken together, the vascular changes in the gingiva of PIDD sub-
jects may be the result of a combination of metabolic and hormonal
imbalances in conjunction with genetic factors.
It is generally accepted that the cellular composition of inﬂamed
gingival tissue is characterized by a predominance of plasma cells
(Chomette et al. 1987, Tew et al. 1989). However, characteristic of
the inﬂammatory inﬁltrate of the diabetic gingiva was that it con-
tained a greater number of plasma cells than seen in healthy controls
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under similar plaque conditions (V). This was the ﬁrst attempt to
quantify the cellular and volumetric composition of the sub–clinical
inﬂammatory lesion of the gingival connective tissue in diabetic sub-
jects (V). These studies provide some new basic information about
the inﬂammatory process as well as the composition of the gingi-
val tissues of randomly chosen long–term poorly controlled diabetic
subjects.
This work conﬁrms and extends earlier ﬁndings which suggest that
good control of diabetes is associated with less severe and less pro-
gressive periodontal changes (Christgau et al. 1998, Collin et al.
1998, Oliver et al. 1998, Taylor et al. 1998). Although diﬀerences in
mean cross–sectional periodontal measurements did not reach signif-
icance (I), such diﬀerences were statistically signiﬁcant in the site–
speciﬁc analysis of each subject’s dentition (III). This represents
one more reason why one should strive to obtain good metabolic
control in diabetes, in particular in patients with poor periodontal
status and other relevant risk factors. Because PIDD patients de-
veloped more diseased sites and displayed more rapid progression in
already existing sites during the two–year follow–up than did CIDD
subjects, we suggest that the poor control of metabolic status in
insulin–dependent diabetes mellitus contributes both to the initia-
tion and to the progression of attachment loss and bone loss. Further
information could be obtained from long–term prospective clinical
studies, which, however, for ethical reasons, cannot be performed
in a totally randomized and controlled manner; it is impossible to
allocate any patients to a ”none or bad treatment” category. Sec-
ondly, it seems indicated and useful to treat gingivitis and periodon-
titis meticulously in diabetic patients with poor metabolic control,
because they seem to respond favorably to periodontal treatment.
In contrast, because PIDD was a marker and probably a risk fac-
tor for periodontitis, periodontal treatment and prophylaxis seem
to be particularly important for the PIDD patients (II, III). Fur-
ther, as demonstrated by these studies, the inﬂammatory response
to plaque may in long–term and uncontrolled IDDM result in a more
periopathogenic microﬂora (IV), more severe loss of collagen, and
connective tissue degradation or degeneration, or both, as well as
in plasma–cell–dominated inﬁltrates associated with reduced num-
bers of ﬁbroblasts than occur in well–controlled IDDM subjects (V).
Therefore, diabetic subjects with unsatisfactory metabolic control
should be analyzed carefully during their annual medical and dental
examinations in order to identify as early as possible subgroups of
diabetic subjects at high risk for periodontal disease. This emerging
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diagnostic, pharmacologic, and risk–based management will require
a design for the beneﬁt for these high–risk patients.
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7. Summary and conclusions
The purpose of the present study was to compare periodontal con-
ditions in a randomly chosen population of poorly controlled insulin–
dependent diabetic (PIDD) and controlled insulin–dependent dia-
betic subjects (CIDD) in a site–speciﬁc manner and over time. Clas-
siﬁcation of the insulin–dependent diabetets mellitus (IDDM) was
based upon longitudinal assessment at annual follow–up visits. Fun-
damental questions were related to the inﬂuence of hyper– and hy-
poglycemia on the initiation, severity, and progression of periodontal
disease in long–term insulin–dependent diabetic subjects. In addi-
tion, vice versa, the impact of periodontal treatment on metabolic
control in IDDM underwent investigation. Further, the qualitative
and quantitative diﬀerences were analyzed in the gingival inﬂamma-
tory process and the composition of the subgingival microﬂora.
Under similar plaque conditions, adult subjects with long–term
PIDD were found to have lost more attachment and alveolar bone
than had subjects with CIDD. These diﬀerences were not equally
obvious when the subjects were classiﬁed according to their history
of medical complications, perhaps in part due to genetic variation
in subjects. Both at the cross–sectional baseline and in longitudinal
one–year and two–year examinations, the PIDD subjects had lost
signiﬁcantly more attachment than lost by the corresponding CIDD
subjects. The inﬂuence of metabolic control on the site-speciﬁc pro-
gression of periodontal disease was also evident. Overall, this sug-
gests that poor metabolic control of DM is prone to accelerate the
progression of periodontitis, especially in the active phase of the pe-
riodontitis.
The beneﬁt of periodontal treatment for on the metabolic control
of the PIDD and CIDD subjects was estimated by levels of glycosy-
lated hemoglobin, but this diﬀerence was not statistically signiﬁcant.
Results of the two–year longitudinal site–by–site examinations con-
ﬁrm that poorly controlled insulin–dependent diabetes mellitus is
strongly related to amount of alveolar bone loss. At all three exam-
inations, the PIDD subjects also exhibited more gingival recession
than did CIDD subjects. Explanations for the increased prevalence
and incidence of periodontal disease were increased risk for gingi-
val inﬂammation, the speciﬁc pattern of the inﬂammatory response,
the periopathogen microﬂora, the accelerated progression of vascu-
lar diseases, and the increased catabolism of the gingival connective
tissue.
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Dark ﬁeld microscopy revealed that the percentage of spirochetes
and motile rods in the periodontally diseased pockets was signiﬁ-
cantly higher in the PIDD than in the CIDD subjects. Moreover, the
PIDD subjects had lower mean percentages of coccoid cells in their
periodontally diseased sites than did CIDD subjects. This suggests
that the metabolic state of IDDM patients aﬀects their periodontal
bacterial microﬂora. Further eﬀorts should be made to analyze the
subgingival microﬂora in long–term hyper– or hypoglycemic diabetic
subjects to identify those periodontopathogens, if any, which act as
mediators rather than markers for the severity and progression of
periodontal disease.
The morphometric analysis of cellular changes in the gingival con-
nective tissue samples revealed, under similar plaque conditions, that
in the PIDD subjects, the inﬂammatory response was clearly inﬂu-
enced by hyperglycemia. In general, the ICT of CIDD subjects did
not diﬀer from the age– and sex–matched control subjects, but vol-
umetric analysis of the healthy gingiva in PIDD subjects demon-
strated elevated plasma cell levels compared to those of control sub-
jects, with decreased numbers of ﬁbroblasts and lymphocytes. In
addition, the non–cellular components, such as collagen ﬁbers, were
also lower in the ICT of PIDD patients. Swollen and proliferated
endothelial cells as well as diminished or totally lacking pericytes
were frequent observations in PIDD subjects.
In conclusion, cellular, vascular, and connective tissue changes
indicating increased catabolism in the gingiva are associated with
poorly controlled long–term insulin–dependent diabetes mellitus.
38
8. Acknowledgements
The study was carried out in 1984–1986 and in 1990–1993 at the
Department of Periodontology, University of Helsinki.
I wish to express my deepest gratitude to my supervisor, Professor
Jukka Ainamo, D.D.S., Ph.D., the former Head of the Institute of
Dentistry at the University of Helsinki, for generously placing its re-
search facilities at my disposal. I am deeply grateful for his excellent
instruction in scientiﬁc research, his vast experience and knowledge,
as well as for his encouragement. I am also most grateful to Do-
cent Timo Sorsa, D.D.S., Ph.D., at the Department of Periodontol-
ogy, University of Helsinki, who has as my supervisor and co–author
kindly guided, supported, and encouraged me through my work as
well as being an expert and inspiring teacher. Professor Yrjo¨ T.
Konttinen, M.D., Ph.D., at the Departments of Oral Medicine and
Anatomy, University of Helsinki, deserves my gratitude for his gen-
erous and excellent supervision. His terriﬁc medical knowledge and
positive attitude could never have been replaced in the ﬁnal stages
of this work.
I am also thankful to my oﬃcial referees, Associate Professor
Go¨ran Gustafsson, D.D.S., Ph.D., and Docent Seppo Leisti, M.D.,
Ph.D., for their positive comments, constructive critisicm, and ex-
pert revision of the manuscript.
I thank Professor Lorne Golub, D.M.D., M.Sc., at Stony Brook,
N.Y., for his vast insight into the complicated ﬁeld of diabetic re-
search, and for his important advice, and meticulous corrections.
Special thanks to Professor Jan Lindhe, D.D.S., Ph.D., for his
insight as primus motor, and Professor Harald Rylander, D.D.S.,
Ph.D., at the University of Gothenburg, for creating the solid basis
for the present study during my period of specialization.
I am deeply grateful to all the diabetic patients participating
in this study, and the endocrinologists, Archiatre Risto Pelkonen,
M.D.S., Ph.D., and Docent Tero Kangas, M.D.S., Ph.D., for the
possibilty to study diabetic patients at the University of Helsinki.
I express humbly my gratitude to Professor Keijo Mattila, D.D.S.,
Ph.D., and Professor Eino Ma¨kila¨, D.D.S., Ph.D., for their support,
to the skillful nurses for taking excellent x–ray pictures, and to Pirjo
Ma¨ki–Jouppila, Marja-Leena Aaltonen, Raita Vahe, and diabetic
nurses Heli Laurell and Pirkko Salmi for assistance at the clinical
examinations.
I am particularly grateful to Eeva Kihlberg, M.Sc., for her encour-
agement and help, and He`le´ne Jave´n for correcting the references. I
39
wish to express my sincere thanks to Carolyn Norris, Ph.D., for edit-
ing of the English language and to Raija Sassi, for visual assistance
in Studies II and V.
Very special thanks go to my dear husband Professor Mika Seppa¨la¨,
Ph.D., for his several daily long–distance calls, loving understanding,
and valuable advice during this demanding work; to my late father,
dear mother, aunt, uncle and sister; to friends and colleagues for
their support; and, last but not least, to our beloved children Sara
and Mark for being my greatest source of happiness and strength.
Without all of you I would have nothing.
This study has been supported by the Finnish Dental Association,
Odontologiska Samfundet i Finland, and the University of Helsinki.
Helsinki, January 2001
Bedia Safkan–Seppa¨la¨
40
9. References
Ainamo, J., Lahtinen, A. & Uitto, V.–J. (1990) Rapid periodontal
destruction in adult humans with poorly controlled diabetes.
A report of two cases. J Clin Periodontol 17, 22–28.
Ainamo, J. & Ainamo, A. (1996) Risk assessment of recurrence of
disease during supportive periodontal care. Epidemiological
considerations. J Clin Periodontol 23, 232–239.
A˚kerblom, H.K., Knip, M., Hyo¨ty, H., Reijonen, H., Virtanen, S.,
Savilahti, E. & Ilonen, J. (1997) Interaction of genetic and
environmental factors in the pathogenesis of insulin–dependent
diabetes mellitus. Clin Chim Acta 257, 143–156.
Alberti, K.G. & Zimmet, P.Z. (1998) Deﬁnition, diagnosis and clas-
siﬁcation of diabetes mellitus and its complications. Part 1:
Diagnosis and classiﬁcation of diabetes mellitus provisional re-
port of a WHO consultation. Diabetic Med 15, 539–553.
Alridge, J.P., Lester, V., Watts, T.L., Collins, A., Viberti, G. & Wil-
son, R.F. (1995) Single–blind studies of the eﬀects of improved
periodontal health on metabolic control in type I diabetes mel-
litus. J Clin Periodontol 22, 271–275.
Anonymous (1991) Endokrinologia. Diabetes mellitus. In: Ther-
apia Fennica. VII ed. Eds Luukkanen, M. & Ristima¨ki, A.
Kandidaattikustannus OY, pp 407–422.
Anonymous (1993) Diabetes Control and Complications Trial Re-
search Group (DCCT). The eﬀect of intensive treatment of di-
abetes on the development and progression of long–term com-
plications in insulin–dependent diabetes mellitus. New Engl J
Med 329, 977–986.
Anonymous (1996) Diabetes and periodontal diseases. Position pa-
per by the Research, Science and Therapy Committee by The
American Academy of Periodontology, Dennison, D.K., Gottsegen,
R. & Rose, L.F. J Periodontol 67, 166–176.
Anonymous (1997) Hypoglycemia in the Diabetes Control and Com-
plications Trial. The Diabetes Control and Complications Trial
Research Group (DCCT). Diabetes 46, 271–286.
Armitage, G.C., Dickinson, W.R., Jenderseck, R.S., Levine, S.M. &
Chambers, D.V. (1982) Relationship between the percentage of
41
subgingival spirochetes and the severity of periodontal diseases.
J Periodontol 53, 550–556.
Bacˇic´, M., Planc´ak, D. & Granic´, M. (1988) CPITN assessment
of periodontal disease in diabetes patients. J Periodontol 59,
816–822.
Bartolucci, E. & Parkes, R.B. (1981) Accelerated periodontal break-
down in uncontrolled diabetes. Oral Surg, Oral Med, Oral
Pathol 52, 387–390.
Bennet, P.H. (1990) Epidemiology of diabetes mellitus. In: Ellen-
berg and Rifkin’s diabetes mellitus: theory and practice, ed.
Rifkin, H. & Porte, D. Jr., Elsevier Science Publishing Co.,
New York, pp. 357–377.
Berg, T.J., Torjesen, P.A., Bangstad, H–J., Bucala, R., O¨sterby,
R. & Hanssen, K.F. (1997) Advanced glycation endproducts
(AGEs) predict changes in kidney morphology of IDDM pa-
tients. Metabolism 46, 661–665.
Berglundh, T., Lindhe, J. & Sterret, J.D. (1991) Clinical and struc-
tural characteristics of periodontal tissues in young and old
dogs. J Clin Periodontol 18, 616–623.
Bergstro¨m, L. & Preber, H. (1994) Tobacco use as a risk factor. J
Periodontol 65, 545–550.
Brandt, R., Landmesser, C., Vogt, L., Hehmke, B., Hanschke, R.,
Kasbohm, J., Hartman, K., Jager, B., Krantz, S. & Michaelis,
D. (1996) Diﬀerential expression of fructosyllysine–speciﬁc re-
ceptors on monocytes and macrophages and possible patho-
physiological signiﬁcance. Diabetol 39, 1140–1147.
Casey, J.I. (1990) Host defense and infections in diabets mellitus. In:
Ellenberg and Rifkin’s diabetes mellitus: theory and practice,
ed. Rifkin, H. & Porte, D. Jr., Elsevier Science Publishing Co.,
New York, pp. 617–625.
Chappey, O., Dosquet, C., Wautier, M–P. & Wautier, J–L. (1997)
Advanced glycation end products, oxidant stress and vascular
lesions. Eur J Clin Invest 27, 97–108.
42
Chomette, G., Auriol, M., Armbuster, D., Szpirglas, H. & Vaillant,
J.M. (1987) Periodontal disease in adults. Immunohistochem-
ical study of inﬂammatory cells and collagen. Rev Stomatol
Chir Maxillofac 88, 372–377.
Christgau, M., Palitzsch, K.D., Schmalz, G., Kreiner, U. & Frenzel,
S. (1998) Healing response to non–surgical periodontal therapy
in patients with diabetes mellitus: clinical, microbiological, and
immunological results. J Clin Periodontol 25, 112–124.
Cianciola, L.J., Park, B.H., Bruck, E., Mosovitch, L. & Genco, R.J.
(1982) Prevalence of periodontal disease in insulin–dependent
diabetes mellitus (juvenile diabetes). J Am Dent Assoc 104,
635–660.
Cohen, D.W., Friedman, L.A., Shapiro, J., Kyle, G.C. & Franklin,
S. (1970) Diabetes mellitus and periodontal disease. Two–year
longitudinal observation. Part I. J Periodontol 41, 709–712.
Collin, H.L., Uusitupa, M., Niskanen, L., Kontturi–Na¨rhi, V., Markka-
nen, H., Koivisto, A.M. & Meurman, J. (1998) Periodontal
ﬁndings in elderly patients with non–insulin–dependent dia-
betes mellitus. J Periodontol 69, 962–966.
Cutler, C.W., Eke, P., Arnold, R.R. & Van Dyke, T.E. (1991) De-
fective neutrophil function in an insulin–dependent diabetes
mellitus patient. A case report. J Periodontol 62, 394–401.
De Toni, S., Piva, E., Lapolla, A., Fontana, G., Fedele, D. & Plebani,
A. (1997) Respiratory burst of neutrophils in diabetic patients
with periodontal disease. Ann NY Acad Sci 832, 363–367.
Dennison, D.K. (1998) Heart attacks, strokes, diabetes and peri-
odontal diseases: the relationship between periodontal health
and systemic diseases. J Gt Houst Dent Soc 69, 22–23.
DeStefano, F., Anda, R.F., Kahn, H.S., Williamson, D.F. & Russell,
C.M. (1993) Dental diseases and risk of coronary heart disease
and mortality. BMJ 306, 688–691.
Ding, Y., Uitto, V-J., Haapasalo, M., Lounatmaa, K., Konttinen,
Y.T., Salo, T., Grenier, D. & Sorsa, T. (1996) Membrane com-
ponents of Treponema denticola trigger proteinase release from
human polymorphonuclear leukocytes. J Dent Res 75, 186–
193.
43
Ding, Y., Haapasalo, M., Kerosuo, E., Lounatmaa, K., Kotiranta, A.
& Sorsa, T. (1997) Release and activation of human neutrophil
matrix metallo– and serine proteinases during phagocytosis of
Fusobacterium nucleatum, Porphyromonas gingivalis, and Tre-
ponema denticola. J Clin Periodontol 24, 237–248.
Doxey, D.L., Cutler, C.W. & Iacopino, A.M. (1998) Diabetes pre-
vents periodontitis–induced increases in gingival platelet de-
rived growth factor–B and interleukin 1–beta in a rat model.
J Periodontol 69, 113–119.
Emrich, J.L., Shlossman, M. & Genco, R.J. (1991) Periodontal dis-
ease in non–insulin–dependent diabetes mellitus. J Periodontol
62, 123–130.
Ervasti, T., Knuuttila, M., Pohjamo, L. & Haukipuro, K. (1985)
Relation between control of diabetes and gingival bleeding. J
Periodontol 56, 154–157.
Feener, E.P. & King, G.L. (1997) Vascular dysfunction in diabetes
mellitus. Lancet 350, S19–S113.
Ficara, A.J., Levin, M.P., Grower, M.F. & Kramer, G.D. (1975)
A comparison of the glucose and protein content of gingival
ﬂuid from diabetics and non–diabetics. J Periodont Res 10,
171–175.
Field, E.A., Longman, L.P., Bucknall, R., Kaye, S.B. Higham, S.M.
& Edgar, W.M. (1997) The establishment of a xerostomia
clinic: a prospective study. Br J Oral Maxillofac Surg 35,
96–103.
Firatli, E. (1997) The relationship between clinical periodontal sta-
tus and insulin–dependent diabetes mellitus. Results after 5
years. J Periodontol 68, 136–140.
Fisher, B.M., Smith, J.G., McCruden, D.C. & Frier, B.M. (1987)
Responses of peripheral blood cells and lymphocyte subpop-
ulations to insulin–induced hypoglycaemia in human insulin–
dependent (type I) diabetes. Eur J Clin Invest 17, 208–213.
Genco, R.J., Wilson, M.E. & De Nardin, E. (1990) Periodontal
complications and neutrophil abnormalities. In: Genco, R.J.,
Goldman, H.M., Cohen, D.W. eds Contemporary periodontics.
St Louis, Mo: C.V. Mosby Company; pp. 203–220.
44
Genco, R.J. (1996) Current view of risk factors for periodontal dis-
eases. J Periodontol 67, 1041–1049.
Gisle’n, G., Nilsson, K.–O. & Matsson, L. (1980) Gingival inﬂamma-
tion in diabetic children related to degree of metabolic control.
Acta Odontol Scand 38, 241–246.
Glavind, L., Lund, B. & Lo¨e, H. (1968) The relationship between
periodontal state and diabetes duration, insulin dosage and
retinal changes. J Periodontol 39, 341–347.
Golub, L.M., Lee, M., Lehrer, G., Nemiroﬀ, A., McNamara, T.F.,
Kaplan, R. & Ramamurthy, N.S. (1983) Minocycline reduces
gingival collagenolytic activity during diabetes. J Periodont
18, 516–526.
Golub, L.M., Suomalainen, K. & Sorsa, T. (1992) Host modulation
of tetracyclines and their chemically modiﬁed analogues. Curr
Op Dent 2, 80–90.
Golub L.M., Lee H.M., Greenwald, R.A., Ryan, M.E., Sorsa, T., Salo
T. & Giannobile, W.V. (1997) A matrix metalloproteinase in-
hibitor reduces bone–type collagen degradation fragments and
speciﬁc collagenases in gingival crevicular ﬂuid during adult
periodontitis. Inﬂamm Res 46, 310–319.
Golub, L.M., Lee, H.M., Ryan, M.E., Giannobile, W.V., Payne, J. &
Sorsa, T. (1998) Tetracycline inhibit connective tissue break-
down by multiple non–antimicrobial mechanisms. Adv Dent
Res 12, 12–26.
Grant–Theule, D.A. (1996) Periodontal disease, diabetes, and im-
mune response: a review of current concepts. J West Soc Pe-
riodontal Periodontal Abstr 44, 69–77.
Groop, L.C. & Tuomi, T. (1997) Non–insulin–dependent diabetes
mellitus – a collision between thrifty genes and an aﬄuent so-
ciety. Ann Med 29, 37–53.
Grossi, S.G., Zambon, J.J., Ho, A.W., Koch, G., Dunford, R.G.,
Machtei, E.E., Norderyd, O.M. & Genco, R.J. (1994) Assess-
ment for risk of periodontal disease. I. Risk indicators for at-
tachment loss. J Periodontol 65, 260–267.
45
Grossi, S.G., Skrepcinski, F.B., DeCaro, T., Zambon, J.J., Cum-
mins, D. & Genco, R.J. (1996) Response to periodontal therapy
in diabetics and smokers. J Periodontol 67, 1094–1102.
Grossi, S.G. & Genco, R.J. (1998) Ann Periodontol. Periodontal
disease and diabetes mellitus: a two-way relationship. Ann
Periodontol 3, 51-61.
Gusberti, F.A., Syed, S.A., Bacon, G., Grossman, N. & Loesche,
W.J. (1983) Puberty gingivitis in insulin–dependent diabetic
children. I. Cross–sectional observations. J Periodontol 54,
714–720.
Harrison, R. & Bowen, W.H. (1987) Flow rate and organic con-
stituents of whole saliva in insulin–dependent diabetic children
and adolescents. Pediatr Dent 9, 287–291.
von Heinrich, H. (1980) Die Beziehung zwischen diabetischer Retino-
pathie und dem Zustand von marginalem Parodont und Rest-
gebiss. Dtsch Zahnaerztl Z 35, 421–425.
von Herrath, M.G., Efrat, S., Oldstone, M.B. & Horwitz, M.S. (1997)
Expression of adenoviral E3 transgenes in beta cells prevents
autoimmune disease. Proc Natl Acad Sci USA 94, 9808–9813.
von Herrath, M. & Holz, A. (1997) Pathological changes in the islet
milieu precede inﬁltration of islets and destruction of beta–cells
by autoreactive lymphocytes in a transgenic model of virus–
induced IDDM. J Autoimmun 10,231–238.
Hiura, H. (1991) An electron microscopic study on the capillar-
ies of oral mucosa in non–insulin–dependent diabetes mellitus.
Shikwa Gahuko 91, 129–148.
Hostetter, M.K. (1990) Handicaps to host defence. Eﬀects of hyper-
glycemia on C3 and Candida albicans. Diabetes 39, 271–275.
Hove, K.A. & Stallard, R.E. (1970) Diabetes and the periodontal
patient.J Periodontol 41, 713–718.
Hugoson, A., Thorstensson, H., Falk, H. & Kuylenstierna, J. (1989)
Periodontal conditions in insulin–dependent diabetics. J Clin
Periodontol 16, 215–223.
Iacopino, A.M. (1995) Diabetic periodontitis: possible lipid–induced
defect in tissue repair through alteration of macrophage phe-
notype and function. Oral Dis 1, 214–229.
46
Ingman, T., Tervahartiala, T., Ding, Y., Tshesche, H., Haerian, A.,
Kinane, D.F., Konttinen, Y.T. & Sorsa, T. (1996) Matrix met-
alloproteinases and their inhibitors in gingival crevicular ﬂuid
and saliva of periodontitis patients. J Clin Periodontol 23,
1127–1132.
Jansen, A., Homo–Delarche, F., Hooijkaas, H., Leenen, P.J., Dard-
enne, M. & Drexhage, H.A. (1994) Immunohistochemical char-
acterization of monocytes–macrophages and dendritic cells in-
volved in the initiation of the insulitis and beta–cell destruction
in NOD mice. Diabetes 43, 667–675.
Kangas, T. (1993) Ambulatory care, inpatient care and metabolic
control of diabetic patients in Finland. STAKES. National
Research and Development Centre for Welfare and Health. Re-
search Reports 29, Jyva¨skyla¨, 1–144.
Kangas, T. (1997) Structure and cost of health care for people with
diabetes in Finland. In: Diabetes in Finland. Publ. of The
Finnish Diabetes Assoc, 11–20.
Karjalainen, K.M., Knuuttila, M.L. & Dickhoﬀ, K.J. (1994) Associa-
tion of the severity of periodontal disease with organ complica-
tions in type I diabetic patients. J Periodontol 65, 1067–1072.
Karjalainen, K.M. & Knuuttila, M.L. (1996) The onset of diabetes
and poor metabolic control increases gingival bleeding in chil-
dren and adolescents with insulin–dependent diabetes mellitus.
J Clin Periodontol 23, 1060–1067.
Karjalainen, K.M., Knuuttila, M.L. & Ka¨a¨r, M.L. (1996) Salivary
factors in children and adolescents with insulin–dependent di-
abetes mellitus. Pediatr Dent 18, 306–311.
Kawamura, M., Fukuda, S., Kawabata, K. & Iwamoto, Y. (1998)
Comparison of health behaviour and oral/medical conditions in
non–insulin–dependent (type II) diabetics and non–diabetics.
Aust Dent J 43, 315–320.
Kinane, D.F. & Chestnutt, I.G. (1997) Relationship of diabetes to
periodontitis. Curr Opin Periodontol 4, 29–34.
Lalla, E., Lamster, I.B. & Schmidt, A.M. (1998a) Enhanced interac-
tion of advanced glycation end products with their cellular re-
ceptor RAGE: implications for the pathogenesis of accelerated
periodontal disease in diabetes. Ann Periodontol 3, 13–19.
47
Lalla, E., Lamster, I.B., Feit, M., Huang, L. & Schmidt, A.M.
(1998b) A murine model of accelerated periodontal disease in
diabetes. J Periodontal Res 33, 387–399.
Lindhe, J., Liljenberg, B. & Listgarten, M. (1980) Some microbio-
logical and histo-pathological features of periodontal disease in
man. J Periodontol 51, 264–270.
Liljenberg, B. & Lindhe, J. (1980) Juvenile periodontitis. Some mi-
crobiological, histopathological and clinical characteristics. J
Clin Periodontol 7, 48–61.
Listgarten, M.A., Ricker, F.H. Jr., Laster, L., Shapiro, J. & Cohen,
D.W. (1974) Vascular basement lamina thickness in the nor-
mal and inﬂamed gingiva of diabetics and non–diabetics. J
Periodontol, 45, 676–684.
Listgarten, M.A. & Hellde´n, L. (1978) Relative distribution of bac-
teria at clinically healthy and periodontally diseased sites in
humans. J Clin Periodontol 5, 115–132.
Listgarten, M.A. & Levin, S. (1981) Positive correlations between
the proportions of subgingival spirochetes, motile bacteria and
suspectibility of human subjects to periodontal deterioration.
J Clin Periodontol 8, 122–138.
Lo¨e, H. & Silness, J. (1963) Periodontal disease in pregnancy. I.
Prevalence and severity. Acta Odont Scand 21, 747–759.
Lo¨e, H. (1967) The Gingival Index, the Plaque Index and the Re-
tention Index. J Periodontol suppl. 38, 610–616.
Lo¨e, H. (1993) Periodontal disease: the sixth complication of dia-
betes mellitus. Diabetes Care 16, 329–334.
Mandell, R.L., Dirienzo, J., Kent, R., Joshipura, K. & Haber, J.
(1992) Microbiology of healthy and diseased periodontal sites
in poorly controlled insulin–dependent diabetics. J Periodontol
63, 274–279.
Marhoﬀer, W., Stein, M., Maeser, E. & Federlin, K. (1992) Impaire-
ment of polymorphonuclear leukocyte function and metabolic
control of diabetes. Diabetes Care 15, 256–260.
Marova, I., Zahejsky, J. & Sehnalova, H. (1995) Non–enzymatic gly-
cation of epidermal proteins of the stratum corneum in diabetic
patients. Acta Diabetol 32, 38–43.
48
Mashimo, P.A., Yamamoto, Y., Slots, J., Park, B.H. & Genco, R.J.
(1983) The periodontal microﬂora of juvenile diabetics. Cul-
ture, immunoﬂuorescence and serum antibody studies. J Pe-
riodontol 54, 420–430.
Mattila, K.J., Nieminen, M.S., Valtonen, V.V., Rasi, R.P., Kesa¨niemi,
Y.A., Syrja¨la¨, S.L., Jungell, P.S., Isoluoma, M., Hietaniemi, K.,
Jokinen, M.J. & Huttunen, J.K. (1989) Association between
dental health and myocardial infarction. BMJ 298, 779–781.
McMullen, J.A., Van Dyke, T.E., Horosewicz, H.U. & Genco, R.J.
(1981) Neutrophil chemotaxis in individuals with advanced pe-
riodontal disease and genetic predisposition to diabetes melli-
tus. J Periodontol 52, 167–173.
Miller, L.S., Manwell, M.A., Newbold, D., Reding, M.E., Rasheed,
A., Blodgett, J. & Kornman K.S. (1992) The relationship be-
tween reduction in periodontal inﬂammation and diabetes con-
trol: a report of 9 cases. J Periodontol 63, 843–848.
Morinushi, T., Lopatin, D.E., Syed, S.A., Bacon, G., Kowalski, C.J.
& Loesche, W.J. (1989) Humoral immune response to selected
subgingival plaque micro–organisms in insulin–dependent dia-
betic children. J Periodontol 60, 199–204.
Nishimura, F., Takahashi, K., Kurihara, M., Takashiba, S. & Mu-
rayama, Y. (1998) Periodontal disease as a complication of
diabetes mellitus. Ann Periodontol 3, 20–29.
Novaes, A.B. Jr., Pereira, A.L., de Moraes, N. & Novaes, A.B. (1991)
Manifestations of insulin–dependent diabetes mellitus in the
periodontium of young Brazilian patients. J Periodontol 62,
116–122.
Novaes, A.B. Jr., Silva, M.A., Batista, E.L. Jr., dos Anjos, B.A.,
Novaes, A.B. & Pereira, A.L. (1997) Manifestation of insulin–
dependent diabetes mellitus in the periodontium of young Brazil-
ian patients. A 10–year follow–up study. J Periodontol 68,
328–334.
Na¨gli, M. (1984) Rechenprogramm (ALICE) zur Verarbeitung mor-
phometrischer Daten fu¨r die stereologische Analyse von Bindegewebe.
Dissertation, Zu¨rich.
Ojima, M., Tamagawa, H., Hayashi, N., Hanioka, T. & Shizukuishi,
S. (1998) Semi–automated measurement of motility of human
49
subgingival microﬂora by image analysis. J Clin Periodontol
25, 612–616.
Oliver, R.C., Tervonen, T. & Flynn, D.G. (1991) Correlation be-
tween control of diabetes and periodontal disease activity mark-
ers. J Dent Res 70, 414.
Oliver, R.C. & Tervonen, T. (1994) Diabetes–a risk factor for peri-
odontitis in adults? J Periodontol 65, 530–538.
Oliver, R.C., Brown, L.J. & Lo¨e, H. (1998) Periodontal diseases in
the United States population. J Periodontol 69, 269–278.
Omar, A.A., Newman. H.N., Bulman, J. & Osborn, J. (1990) Dark-
ground microscopy of subgingival plaque from the top to the
bottom of the periodontal pocket. J Clin Periodontol 17, 364–
370.
Papapanou, P.N. (1997) Periodontal diseases: epidemiology. Ann
Periodontol 1, 1–36.
Perschel, W.T., Langefeld, T.W. & Federlin, K. (1995) Susceptibility
to infections in diabetes–eﬀects on metabolism. Immun Infekt
23, 196–200.
Pinson, M., Hoﬀman W.H., Garnick, J.F. & Litaker, M.S. (1995)
Periodontal disease and type I diabetes mellitus in children
and adolescents. J Clin Periodontol 22, 118–123.
Pohjamo, L, Tervonen, T., Knuuttila, M. & Nurkkala, H. (1995)
Adult diabetics and non–diabetic subjects as users of dental
services. A longitudinal study. Odontol Scand 53, 112–114.
Pohjamo, L. (1996) Periodontal disease, caries and dental compli-
ance in diabetic adults. A longitudinal study. Acta Universitas
Ouluensis D Medica 380, 1–58.
de Pommereau, V., Dargent–Pare, C., Robert, J.J. & Brion, M.
(1992) Periodontal status in insulin–dependent adolescents. J
Clin Periodontol 19, 628–632.
Ramamurthy, N.S. & Golub, L.M. (1983) Diabetes increases colla-
genase activity in extracts of rat gingiva and skin. J Periodont
Res 18, 23–30.
Ray, H.G. & Orban, B. (1950) Gingival structures in diabetes mel-
litus. J Periodontol 21, 85–95.
50
Rose, L.F., Stienberg, B.J. & Atlas, S.L. (1995) Periodontal man-
agement of the medically comprised patient. Periodontol 9,
165–175.
Rylander, H., Ramberg, P., Blohme´, G. & Lindhe, J. (1987) Preva-
lence of periodontal disease in young diabetics. J Clin Peri-
odontol 14, 38–43.
Safkan, B. & Knuuttila, M. (1984) Corticosteroid therapy and peri-
odontal disease. J Clin Periodontol 11, 515–522.
Salvi, G.E., Yalda, B., Collins, J.G., Jones, B.H., Smith, F.W.,
Arnold, R.R. & Oﬀenbacher, S. (1997) Inﬂammatory media-
tor response as a potential risk marker for periodontal diseases
in insulin–dependent diabetes mellitus. J Periodontol 68, 127–
135.
Salvi, G.E., Beck, J.D. & Oﬀenbacher, S. (1998) PGE2, IL−1β, and
TNF−α responses in diabetics as modiﬁers of periodontal dis-
ease expression. Ann Periodontol 3, 40–50.
Sandholm, L., Swanljung, O., Ryto¨maa, I., Kaprio, E.A. &Ma¨enpa¨a¨,
J. (1989a) Morphotypes of the subgingival microﬂora in dia-
betic adolescents in Finland. J Periodontol 60, 526–528.
Sandholm, L., Swanljung, O., Ryto¨maa, I., Kaprio, E.A. &Ma¨enpa¨a¨,
J. (1989b) Periodontal status of Finnish adolescents with insulin–
dependent diabetes mellitus. J Clin Periodontol 16, 617–620.
Sandros, J., Papapanou,P. & Dahle´n, G. (1993) Porphyromonas gin-
givalis invades oral epithelial cells in vitro. J Periodont Res 28,
219–226.
Sasaki, T., Ramamurthy, N.S., Yu, Z. & Golub, L. (1992) Tetra-
cycline administration increases protein (presumably procolla-
gen) synthesis and secretion in periodontal ligament ﬁbroblasts
of streptozotocin–induced diabetic rats. J Periodont Res 27,
631–639.
Sastrowijoto, S.H., van der Velden, U., van Steenberghen, T.J.M.,
Hillemans, P., Hart, A.A.M., de Graaﬀ, J. & Abraham–Inpijn,
L. (1990) Improved metabolic control, clinical periodontal sta-
tus and subgingival microbiology in insulin–dependent diabetes
mellitus. A prospective study. J Clin Periodontol 17, 233–242.
51
Sbordone, L., Ramaglia, L., Barone, A., Ciaglia, R.N. & Iacono,
V.J. (1998) Periodontal status and subgingival microbiota of
insulin–dependent juvenile diabetics: a 3–year longitudinal study.
J Periodontol 69, 120–128.
Schmidt, A.M., Weidman, E., Lalla, E., Yan, S.D., Hori, O., Cao,
R., Brett, J.G. & Lamster, I.B. (1996) Advanced glycation end
products (AGEs) induce oxidant stress in the gingiva: a po-
tential mechanism underlying accelerated periodontal disease
associated with diabetes. J Periodont Res 31, 508–515.
Schroeder, H.E. (1967) Standardisierte cytologische Untersuchung
von Biopsien oralen Gewebes. Helv Odontol Acta 11, 189–204.
Schroeder, H.E. & Mu¨nzel–Pedrazzoli, S. (1973) Correlated morpho-
metric and biochemical analysis of gingival tissue. Morphome-
tric model, tissue sampling and test of stereologic procedures.
J Microsc 99, 301–329.
Schubert, S. & Heesemann, J. (1995) Infections in diabetes mellitus.
Immun Infekt 23, 200-204.
Serizawa, N. (1988) An electron microscopic study on the capillaries
of buccal mucosa and retina in streptozotocin–induced diabetic
rats. Shikwa Gahuko 88, 85–109.
Seymour, G.J. (1991) Importance of the host response in the peri-
odontium. J Clin Periodontol 18, 421–426.
Shlossman, M., Knowler, W.C., Pettitt, D.J. & Genco, R.J. (1990)
Type 2 diabetes mellitus and periodontal disease. J Am Dent
Ass 121, 532–536.
Silness, J. & Lo¨e, H. (1964) Periodontal disease in pregnancy. II.
Correlation between oral hygiene and periodontal condition.
Acta Odont Scand 22, 121–135.
Slots, J. & Listgarten, M. (1988) Bacteroides gingivalis, Bacteroides
intermedius and Actinobacillus actinomycetemcomitans in hu-
man periodontal diseases. J Clin Periodontol 15, 85–93.
Smith, G.T., Greenbaum, C.J., Johnson, B.D. & Persson, G.R.
(1996) Short–term response to periodontal therapy in insulin–
dependent diabetic patients. J Periodontol 67, 794–802.
52
Sorsa, T., Suomalainen, K., Helenius, J., Lindy, S., Saari, H., Kont-
tinen, Y.T. & Uitto, V–J. (1990) Periodontal disease. N Engl
J Med 323, 133–135.
Sorsa, T., Ingman, T., Suomalainen, K., Halinen, S., Saari, H., Kont-
tinen, Y.T., Uitto, V–J. & Golub, L.M. (1992a) Cellular source
and tetracycline–inhibition of gingival crevicular ﬂuid collage-
nase of patients with labile diabetes mellitus. J Clin Periodon-
tol 19, 146–149.
Sorsa, T., Ingman, T., Suomalainen, K., Haapasalo, M., Konttinen,
Y.T., Lindy, O., Saari, H. & Uitto, V–J. (1992b) Identiﬁcation
of proteases from periodontopathogenic bacteria as activators
of latent human neutrophil and ﬁbroblast–type interstitial col-
lagenases. Infect Immun 60, 4491–4495.
Sorsa, T. Lukinmaa, P–L., Westerlund, U., Ingman, T., Ding, Y.,
Tschesche, H., Konttinen, Y.T., Helaakoski, T. & Salo, T.
(1996) The expression, activation and chemotherapeutic inhibi-
tion of matrix metalloproteinase–8 (neutrophil collagenase/col-
lagenase–2) in inﬂammation. In: Biological mechanisms of
tooth movement and craniofacial adaptation. Eds Davidovitch,
Z. & Norton L.A. Harvard Society for the Advancement of Or-
thodontics. Boston, MA, EBSCO Media, 317–323.
Sorsa, T., Ramamurthy, N.S., Vernillo, A.T., Zhang, X., Kontti-
nen, Y.T., Rifkin, B.R. & Golub, L.M. (1998) Functional sites
of chemically–modiﬁed tetracyclines (CMT): inhibition of ox-
idative activation of human neutrophil and chicken osteoclast
pro–matrix–metalloproteinases. J Rheumatol, 25, 975–982.
Soskolne, W.A. (1998) Epidemiological and clinical aspects of peri-
odontal diseases in diabetes. Ann Periodontol, 3, 3–12.
Sowers, J.R. & Epstein, M. (1995) Diabetes mellitus and associated
hypertension, vascular disease, and nephropathy: An update.
Hypertension 26, 869–879.
Tanner, A.C., Socransky, S.S. & Goodson, J.M. (1984) Microbiota of
periodontal pockets losing crestal alveolar bone. J Periodontal
Res 19, 279–291.
Tater, D., Tepaut, B., Bercovici, J.P. & Youinou, P. (1987) Polymor-
phonuclear cell derangements in type I diabetes. Horm Metab
Res 19, 642–647.
53
Taylor, G.W., Burt, B.A., Becker, M.P., Genco, R.J., Shlossman,
M., Knowler, W.C. & Pettitt, D.J. (1996) Severe periodontitis
and risk for poor glycemic control in patients with non–insulin–
dependent diabetes mellitus. J Periodontol 67, 1085–1093.
Taylor, G.W., Burt, B.A., Becker, M.P., Genco, R.J. & Shlossman,
M. (1998) Glycemic control and alveolar bone loss progression
in type 2 diabetes. Ann Periodontol 3, 30–39.
Taylor, G.W.& Becker, M.P. (1998) Increased eﬃciency of analyses:
cumulative logistic regression vs ordinary logistic regression.
Community Dent Oral Epidemiol 26, 1-6.
Tervonen, T. & Knuuttila, M. (1986) Relation of diabetes control to
periodontal pocketing and alveolar bone level. Oral Surg Oral
Med Oral Pathol 61, 346– 349.
Tervonen, T., Knuuttila, M., Pohjamo, L. & Nurkkala, H. (1991)
Immediate response to non–surgical periodontal treatment in
subjects with diabetes mellitus. J Clin Periodontol 18, 65–68.
Tervonen, T., Oliver, R.C. & Bereuter, J. (1991) Control of diabetes
mellitus and periodontal health. J Dent Res 70, 414.
Tervonen, T. & Oliver, R.C. (1993) Long–term control of diabetes
mellitus and periodontitis. J Clin Periodontol 20, 431–435.
Tervonen, T., Oliver, R.C., Wolﬀ, L.F., Bereuter, J., Anderson, L.A.
& Aeppli, D.M. (1994) Prevalence of periodontal pathogens
with varying metabolic control of diabetes mellitus. J Clin
Periodontol 21, 375–379.
Tervonen, T. & Karjalainen, K. (1997) Periodontal disease related
to diabetic status. A pilot study of the response to periodontal
therapy in type I diabetes. J Clin Periodontol 24, 505–510.
Tew, J., Engel, D. & Mangan, D. (1989) Polyclonal B–cell activation
in periodontitis. J Periodontal Res 24, 225–241.
Thorstensson, H., Falk, H., Hugoson, A. & Kuylenstierna, J. (1989)
Dental care habits and knowledge of oral health in insulin–
dependent diabetics. Scand J Dent Res 97, 207–215.
Thorstensson, H. & Hugoson, A. (1993) Periodontal disease expe-
rience in adult long–duration insulin–dependent diabetics. J
Clin Periodontol 20, 352–358
54
Thorstensson, H. (1995) Periodontal disease in adult insulin–dependent
diabetics. Swed Dent J suppl. 107, 1–68.
Thorstensson, H., Kuylenstierna, J. & Hugoson, A. (1996) Medical
status and complications in relation to periodontal disease in
insulin–dependent diabetics. J Clin Periodontol, 23, 194–202.
Trieger, N. & Boguslaw, B (1990) The mouth in diabetes. In: Ellen-
berg and Rifkin’s diabetes mellitus: theory and practice, ed.
Rifkin, H. & Porte, D. Jr., Elsevier Science Publishing Co.,
New York, pp. 850–855.
Tuomilehto, J. & Reunanen, A. (1997) Epidemiology of diabetes
mellitus in Finland. In: Diabetes in Finland. Publ. of The
Finnish Diabetes Assoc, 4–10.
Ueta, E., Osaki, T., Yoneda, K. & Yamamoto, T. (1993) Prevalence
of diabetes mellitus in odontogenic infections and oral candidi-
asis: an analysis of neutrophil suppression. J Oral Pathol Med
22, 168–174.
Watkins, P.J., Drury, P.L. & Howell, S. L. (1996) Diabetes and its
management. 5th ed, Blackwell Science Inc.
Weibel, E.R. (1969) Stereologic principles for morphometry in elec-
tron microscopic cytology. Int Rev Cytol 26, 235–302.
Westerlund, U., Ingman, T., Lukinmaa, P–L., Salo, T., Kjeldsen, L.,
Borregaard, N., Tja¨derhane, L., Konttinen, Y.T. & Sorsa, T.
(1996) Human neutrophil gelatinase and associated lipocalin
in adult and localized juvenile periodontitis. J Dent Res 75,
1553–1563.
Westfelt, E., Rylander, H., Blohme´, G., Jonasson, P. & Lindhe, J.
(1996) The eﬀect of periodontal therapy in diabetics. Results
after 5 years. J Clin Periodontol 23, 92–100.
WHO Study Group (1985) Diabetes Mellitus. Geneva, WHO Tech-
nical Reports, Series 727.
Williams Jr., R.C. & Mahan, C.J. (1960) Periodontal disease and
diabetes in young adults. JAMA 172, 776–778.
Willershausen–Zo¨nnchen, B. & Hamm, G. (1988) Untersuchungen
u¨ber den Einﬂuss des Diabetes mellitus (Typ I) auf das Paro-
dont. Dtsch Zahnaerztl Z 43, 600–604.
55
Willershausen–Zo¨nnchen, B., Lemmen, C. & Hamm, G. (1991) In-
ﬂuence of high glucose concentrations on glycosaminoglycan
and collagen synthesis in cultured human gingival ﬁbroblasts.
J Clin Periodontol 18, 190–195.
Vlassara, H. & Bucala, R. (1995) Advanced glycation endproducts
(AGEs) and diabetes complications: an update. In: Diabetes
Annual. Eds. Home, P., Marshall, S., Amsterdam, Elsevier,
pp 227–244.
Wolf, J. (1977) Dental and periodontal conditions in diabetes melli-
tus. Proc Finn Dent Soc 73, 1–56.
Yalda, B., Oﬀenbacher, S. & Collins, J.G. (1994) Diabetes as a mod-
iﬁer of periodontal disease expression. Periodontol 2000 6, 37–
49.
Yki–Ja¨rvinen, H., Sammalkorpi, K., Koivisto V.A. & Nikkila¨, E.A.
(1989) Severity, duration, and mechanisms of insulin resistance
during acute infections. J Clin Endocrinol Metab 69, 317–323.
Yki–Ja¨rvinen, H. (1999) Hyperglykemian hoito aikuistyypin dia-
beteksessa. Duodecim 10, 1155–1164.
Yoon, J.W. (1991) Role of viruses in the pathogenesis of IDDM. Ann
Med 36, 437–445.
Zambon, J.J., Reynolds, H., Fisher, J.G., Shlossman, M., Dunford,
R. & Genco, R.J. (1988) Microbiological and immunological
studies of adult periodontitis in patients with non–insulin–
dependent diabetes mellitus. J Periodontol 59, 23–31.
Zappa, U.E., Polson, A.M., Eisenberg, A.D. & Espeland, M.A. (1986)
Microbial population and active tissue destruction in experi-
mental periodontitis. J Clin Periodontol 13, 117–125.
10. Studies I – V
